1
|
Tsurudome Y, Yoshida Y, Hamamura K, Ogino T, Yasukochi S, Yasuo S, Iwamoto A, Yoshihara T, Inazumi T, Tsuchiya S, Takeo T, Nakagata N, Higuchi S, Sugimoto Y, Tsuruta A, Koyanagi S, Matsunaga N, Ohdo S. Prostaglandin F2α Affects the Cycle of Clock Gene Expression and Mouse Behavior. Int J Mol Sci 2024; 25:1841. [PMID: 38339119 PMCID: PMC10855224 DOI: 10.3390/ijms25031841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 01/26/2024] [Accepted: 02/01/2024] [Indexed: 02/12/2024] Open
Abstract
Prostaglandins are bioactive compounds, and the activation of their receptors affects the expression of clock genes. However, the prostaglandin F receptor (Ptgfr) has no known relationship with biological rhythms. Here, we first measured the locomotor period lengths of Ptgfr-KO (B6.129-Ptgfrtm1Sna) mice and found that they were longer under constant dark conditions (DD) than those of wild-type (C57BL/6J) mice. We then investigated the clock gene patterns within the suprachiasmatic nucleus in Ptgfr-KO mice under DD and observed a decrease in the expression of the clock gene cryptochrome 1 (Cry1), which is related to the circadian cycle. Moreover, the expression of Cry1, Cry2, and Period2 (Per2) mRNA were significantly altered in the mouse liver in Ptgfr-KO mice under DD. In the wild-type mouse, the plasma prostaglandin F2α (PGF2α) levels showed a circadian rhythm under a 12 h cycle of light-dark conditions. In addition, in vitro experiments showed that the addition of PTGFR agonists altered the amplitude of Per2::luc activity, and this alteration differed with the timing of the agonist addition. These results lead us to hypothesize that the plasma rhythm of PGF2α is important for driving clock genes, thus suggesting the involvement of PGF2α- and Ptgfr-targeting drugs in the biological clock cycle.
Collapse
Affiliation(s)
- Yuya Tsurudome
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.T.); (T.O.); (S.Y.); (S.K.)
| | - Yuya Yoshida
- Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.Y.); (K.H.)
| | - Kengo Hamamura
- Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.Y.); (K.H.)
| | - Takashi Ogino
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.T.); (T.O.); (S.Y.); (S.K.)
| | - Sai Yasukochi
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.T.); (T.O.); (S.Y.); (S.K.)
| | - Shinobu Yasuo
- Regulation in Metabolism and Behavior, Faculty of Agriculture, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan; (S.Y.)
| | - Ayaka Iwamoto
- Regulation in Metabolism and Behavior, Faculty of Agriculture, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan; (S.Y.)
| | - Tatsuya Yoshihara
- SOUSEIKAI Fukuoka Mirai Hospital Clinical Research Center, 3-5-1 Kashiiteriha, Higashi-ku, Fukuoka 813-0017, Japan;
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1, Oe-Honmachi, Chuo-ku, Kumamoto 862-0973, Japan; (T.I.); (S.T.); (Y.S.)
| | - Soken Tsuchiya
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1, Oe-Honmachi, Chuo-ku, Kumamoto 862-0973, Japan; (T.I.); (S.T.); (Y.S.)
| | - Toru Takeo
- Division of Reproductive Engineering, Center for Animal Resources and Development (CARD), Institute of Resource Development and Analysis, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan;
| | - Naomi Nakagata
- Division of Reproductive Biotechnology and Innovation, Center for Animal Resources and Development (CARD), Institute of Resource Development and Analysis, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan;
| | - Shigekazu Higuchi
- Department of Human Life Design and Science, Faculty of Design, Kyushu University, 4-9-1 Shiobaru, Minami-ku, Fukuoka 815-8540, Japan;
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1, Oe-Honmachi, Chuo-ku, Kumamoto 862-0973, Japan; (T.I.); (S.T.); (Y.S.)
| | - Akito Tsuruta
- Department of Glocal Healthcare Science, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan;
| | - Satoru Koyanagi
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.T.); (T.O.); (S.Y.); (S.K.)
- Department of Glocal Healthcare Science, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan;
| | - Naoya Matsunaga
- Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.Y.); (K.H.)
| | - Shigehiro Ohdo
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; (Y.T.); (T.O.); (S.Y.); (S.K.)
| |
Collapse
|
2
|
Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Abbracchio MP, Abraham G, Agoulnik A, Alexander W, Al-Hosaini K, Bäck M, Baker JG, Barnes NM, Bathgate R, Beaulieu JM, Beck-Sickinger AG, Behrens M, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Boulay F, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Cox HM, Csaba Z, Dahlgren C, Dent G, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo EJ, Fong T, Fumagalli M, Gainetdinov RR, Garelja ML, de Gasparo M, Gerard C, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Grätz L, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay DL, Heinemann A, Herr D, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kitazawa T, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Larhammar D, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Li XX, Lolait SJ, Lupp A, Macrae R, Maguire J, Malfacini D, Mazella J, McArdle CA, Melmed S, Michel MC, Miller LJ, Mitolo V, Mouillac B, Müller CE, Murphy PM, Nahon JL, Ngo T, Norel X, Nyimanu D, O'Carroll AM, Offermanns S, Panaro MA, Parmentier M, Pertwee RG, Pin JP, Prossnitz ER, Quinn M, Ramachandran R, Ray M, Reinscheid RK, Rondard P, Rovati GE, Ruzza C, Sanger GJ, Schöneberg T, Schulte G, Schulz S, Segaloff DL, Serhan CN, Singh KD, Smith CM, Stoddart LA, Sugimoto Y, Summers R, Tan VP, Thal D, Thomas WW, Timmermans PBMWM, Tirupula K, Toll L, Tulipano G, Unal H, Unger T, Valant C, Vanderheyden P, Vaudry D, Vaudry H, Vilardaga JP, Walker CS, Wang JM, Ward DT, Wester HJ, Willars GB, Williams TL, Woodruff TM, Yao C, Ye RD. The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. Br J Pharmacol 2023; 180 Suppl 2:S23-S144. [PMID: 38123151 DOI: 10.1111/bph.16177] [Citation(s) in RCA: 30] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023] Open
Abstract
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (https://www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.16177. G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
Collapse
Affiliation(s)
- Stephen P H Alexander
- School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK
| | - Arthur Christopoulos
- Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, 3052, Australia
| | | | - Eamonn Kelly
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK
| | - Alistair A Mathie
- School of Engineering, Arts, Science and Technology, University of Suffolk, Ipswich, IP4 1QJ, UK
| | - John A Peters
- Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK
| | - Emma L Veale
- Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK
| | - Jane F Armstrong
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Elena Faccenda
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Simon D Harding
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Jamie A Davies
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | | | - George Abraham
- Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK
| | | | | | | | - Magnus Bäck
- Karolinska University Hospital, Stockholm, Sweden
| | - Jillian G Baker
- School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK
| | | | - Ross Bathgate
- Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
| | | | | | - Maik Behrens
- Technical University of Munich, Freising, Germany
| | | | | | | | - Victoria Blaho
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | - Corinne Bousquet
- French Institute of Health and Medical Research (INSERM), Toulouse, France
| | | | | | | | | | | | | | | | | | - Bice Chini
- University of Milan Bicocca, Vedano al Lambro, Italy
| | - Jerold Chun
- University of California San Diego, La Jolla, USA
| | | | | | | | | | | | - Zsolt Csaba
- French Institute of Health and Medical Research (INSERM), Paris, France
| | | | | | | | - Pascal Dournaud
- French Institute of Health and Medical Research (INSERM), Paris, France
| | | | | | | | - Tung Fong
- Labcorp Drug Development, Somerset, USA
| | | | | | | | | | | | | | | | | | - Cyril Goudet
- French National Centre for Scientific Research, Montpellier, France
| | | | - Karen J Gregory
- Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, 3052, Australia
| | - Andrew L Gundlach
- Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
| | - Jörg Hamann
- Amsterdam University, Amsterdam, The Netherlands
| | | | | | | | | | - Deron Herr
- San Diego State University, San Diego, USA
| | | | - Nicholas D Holliday
- School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK
| | | | | | | | | | | | | | | | | | - Ralf Jockers
- French Institute of Health and Medical Research (INSERM), Paris, France
| | | | | | | | | | | | - Yasuyuki Kihara
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | | | | | | | | | | | - Katie Leach
- Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, 3052, Australia
| | | | - John D Lee
- University of Queensland, Brisbane, Australia
| | | | | | - Xaria X Li
- University of Queensland, Queensland, Australia
| | - Stephen J Lolait
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK
| | - Amelie Lupp
- Friedrich Schiller University Jena, Jena, Germany
| | | | - Janet Maguire
- Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK
| | | | - Jean Mazella
- French National Centre for Scientific Research (CNRS), Valbonne, France
| | - Craig A McArdle
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK
| | | | | | | | | | - Bernard Mouillac
- French National Centre for Scientific Research, Montpellier, France
| | | | | | - Jean-Louis Nahon
- French National Centre for Scientific Research (CNRS), Valbonne, France
| | - Tony Ngo
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | - Xavier Norel
- French Institute of Health and Medical Research (INSERM), Paris, France
| | | | - Anne-Marie O'Carroll
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK
| | - Stefan Offermanns
- Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
| | | | | | | | | | | | | | | | - Manisha Ray
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | - Leigh A Stoddart
- School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK
| | | | | | | | | | | | | | | | | | | | | | - Thomas Unger
- Maastricht University, Maastricht, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Richard D Ye
- The Chinese University of Hong Kong, Shenzhen, China
| |
Collapse
|
3
|
Guadagnin AR, Fehlberg LK, Thomas B, Sugimoto Y, Shinzato I, Cardoso FC. Feeding rumen-protected lysine prepartum alters placental metabolism at a transcriptional level. J Dairy Sci 2023; 106:6567-6576. [PMID: 37532623 DOI: 10.3168/jds.2022-22390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Accepted: 02/24/2023] [Indexed: 08/04/2023]
Abstract
Rumen-protected Lys (RPL) fed to Holstein cows prepartum resulted in a greater intake and improved health of their calves during the first 6 wk of life. However, whether increased supply of Lys in late gestation can influence placental tissue and, if so, which pathways are affected remain to be investigated. Therefore, we hypothesize that feeding RPL during late gestation could modulate placental metabolism, allowing for improved passage of nutrients to the fetus and thus influencing the offspring development. Therefore, we aimed to determine the effects of feeding RPL (AjiPro-L Generation 3, Ajinomoto Health and Nutrition North America) prepartum (0.54% DM of TMR) on mRNA gene expression profiles of placental samples of Holstein cows. Seventy multiparous Holstein cows were randomly assigned to 1 of 2 dietary treatments, consisting of TMR top-dressed with RPL (PRE-L) or without (control, CON), fed from 27 ± 5 d prepartum until calving. After natural delivery (6.87 ± 3.32 h), placentas were rinsed with physiological saline (0.9% sodium chloride solution) to clean any dirtiness from the environment and weighed. Then, 3 placentomes were collected, one from each placental region (cranial, central, and caudal), combined and flash-frozen in liquid nitrogen to evaluate the expression of transcripts and proteins related to protein metabolism and inflammation. Placental weights did not differ from cows in PRE-L (15.5 ± 4.03 kg) and cows in CON (14.5 ± 4.03 kg). Feeding RPL prepartum downregulated the expression of NOS3 (nitric oxide synthase 3), involved in vasodilation processes, and SOD1, which encodes the enzyme superoxide dismutase, involved in oxidative stress processes. Additionally, feeding RPL prepartum upregulated the expression of transcripts involved in energy metabolism (SLC2A3, glucose transporter 3; and PCK1, phosphoenolpyruvate carboxykinase 1), placental metabolism and cell proliferation (FGF2, fibroblast growth factor 2; FGF2R, fibroblast growth factor 2 receptor; and PGF, placental growth factor), Met metabolism (MAT2A, methionine adenosyltransferase 2-α), and tended to upregulate IGF2R (insulin-like growth factor 2 receptor). Placental FGF2 and LRP1 (low-density lipoprotein receptor-related protein 1) protein abundance were greater for cows that received RPL prepartum than cows in CON. In conclusion, feeding RPL to prepartum dairy cows altered uteroplacental expression of genes and proteins involved in cell proliferation, and in metabolism and transport of glucose. Such changes are illustrated by increased expression of SLC2A3 and PCK1 and increased protein abundance of FGF2 and LRP1 in uteroplacental tissue of cows consuming RPL.
Collapse
Affiliation(s)
- A R Guadagnin
- Department of Animal Sciences, University of Illinois Urbana-Champaign, IL 61801
| | - L K Fehlberg
- Department of Animal Sciences, University of Illinois Urbana-Champaign, IL 61801
| | - B Thomas
- Department of Animal Sciences, University of Illinois Urbana-Champaign, IL 61801
| | | | | | - F C Cardoso
- Department of Animal Sciences, University of Illinois Urbana-Champaign, IL 61801.
| |
Collapse
|
4
|
Fehlberg LK, Guadagnin AR, Thomas BL, Ballou M, Loor JJ, Sugimoto Y, Shinzato I, Cardoso FC. Feeding rumen-protected lysine altered immune and metabolic biomarkers in dairy cows during the transition period. J Dairy Sci 2023; 106:2989-3007. [PMID: 36797190 DOI: 10.3168/jds.2022-22349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2022] [Accepted: 09/13/2022] [Indexed: 02/16/2023]
Abstract
This experiment was conducted to determine the effects of feeding rumen-protected lysine (RPL; AjiPro-L Generation 3, Ajinomoto Health and Nutrition North America Inc.) from -26 ± 4.6 d prepartum (0.54% RPL of dietary dry matter intake) to 28 d postpartum (0.39% RPL of dietary dry matter intake) on immunometabolic status and liver composition in dairy cows. Seventy-five multiparous Holstein cows, blocked by parity, previous 305-d mature-equivalent milk production, expected calving date, and body condition score during the far-off dry period were assigned to 1 of 4 dietary treatments in a randomized, complete block design with a 2 × 2 factorial arrangement of treatments. Treatments prepartum consisted of total mixed ration top dressed with RPL (PRE-L) or without RPL (PRE-C), and postpartum treatments consisted of total mixed ration top dressed PRE-L prepartum and postpartum, PRE-L prepartum and PRE-C postpartum, PRE-C prepartum and PRE-L postpartum, and PRE-C prepartum and postpartum in 300 g of molasses. Blood samples were taken on -7 ± 0.5, 0 ± 0.5, 7 ± 0.9, 14 ± 0.9, and 28 ± 0.5 d relative to calving. Whole blood samples were taken on -14 ± 0.5, -7 ± 0.5, 7 ± 0.9, and 14 ± 0.9 d relative to calving for oxidative burst and phagocytic capacity of monocytes and neutrophils. Liver samples were collected via a biopsy on -12 ± 4.95 and 13 ± 2.62 d relative to calving and analyzed for liver composition (triacylglyceride and carnitine concentrations), mRNA expression of hepatic genes, and protein abundance. Protein abundance was calculated by normalizing intensity bands for a specific protein with glyceraldehyde-3-phosphate dehydrogenase. Concentrations of haptoglobin and glutathione peroxidase activity in plasma were lower at d 0 for cows in PRE-L (102 µg/mL and 339 nmol/min per mL, respectively) compared with cows in PRE-C (165 µg/mL and 405 nmol/min per mL, respectively). Oxidative burst capacity in monocytes tended to be greater on d 7 postpartum for cows in PRE-L (65.6%) than cows in PRE-C (57.5%). Additionally, feeding RPL altered the mRNA expression in liver tissue prepartum [decreased INSR (insulin receptor), CPT1A (carnitine palmitoyltransferase 1A), and IL1B (interleukin 1 β)] and postpartum [increased IL8 (interleukin 8), EHMT2 (euchromatic histone lysine methyltransferase 2), TSPO (translocator protein), and SLC3A2 (solute carrier family 3 member 2); and decreased SLC7A1 (solute carrier family 7 member 1), SOD1 (superoxide dismutase 1), and SAA3 (serum amyloid A 3)] compared with cows not consuming RPL]. Additionally, cows in the PRE-C prepartum and PRE-L postpartum treatment tended to have greater protein abundance of mTOR postpartum compared with the PRE-C prepartum and postpartum treatment. Protein abundance of SLC7A7 (solute carrier family 7 member 7) pre- and postpartum tended to be greater and BBOX1 (gamma-butyrobetaine dioxygenase 1) tended to be less when RPL was consumed prepartum. In conclusion, cows that consumed RPL during the transition period had molecular changes related to liver composition, enhanced liver function indicated by greater total protein and albumin concentrations in plasma, and improved immune status indicated by decreased haptoglobin, glutathione peroxidase activity, and immune related mRNA expression.
Collapse
Affiliation(s)
- L K Fehlberg
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - A R Guadagnin
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - B L Thomas
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - M Ballou
- Department of Animal Science and Food Science, Texas Tech University, Lubbock 79409
| | - J J Loor
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - Y Sugimoto
- Ajinomoto Co. Inc., Tokyo 104-8315, Japan
| | - I Shinzato
- Ajinomoto Co. Inc., Tokyo 104-8315, Japan
| | - F C Cardoso
- Department of Animal Sciences, University of Illinois, Urbana 61801.
| |
Collapse
|
5
|
Guadagnin A, Fehlberg L, Thomas B, Sugimoto Y, Shinzato I, Cardoso F. Effect of feeding rumen-protected lysine through the transition period on postpartum uterine health of dairy cows. J Dairy Sci 2022; 105:7805-7819. [DOI: 10.3168/jds.2022-21934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Accepted: 05/06/2022] [Indexed: 11/19/2022]
|
6
|
Inazumi T, Sugimoto Y. Metabolic Regulation in Adipocytes by Prostanoid Receptors. Biol Pharm Bull 2022; 45:992-997. [DOI: 10.1248/bpb.b22-00270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University
| |
Collapse
|
7
|
Hashimoto M, Makino N, Inazumi T, Yoshida R, Sugimoto T, Tsuchiya S, Sugimoto Y. Effects of an ω3 fatty acid-biased diet on luteolysis, parturition, and uterine prostanoid synthesis in pregnant mice. Biochem Biophys Res Commun 2022; 589:139-146. [PMID: 34920379 DOI: 10.1016/j.bbrc.2021.12.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Accepted: 12/09/2021] [Indexed: 11/16/2022]
Abstract
The ω3 polyunsaturated fatty acids (PUFAs) are known to have beneficial effects on health and diseases, and hence their intake is encouraged. However, it remains unknown as to how ω3 PUFAs affect female reproduction processes, in which ω6 PUFA-derived prostaglandin (PG) E2 and PGF2α play crucial roles. We therefore compared female reproductive performance between ω3 PUFA-biased linseed oil diet-fed (Lin) mice and ω6 PUFA-biased soybean oil diet-fed (Soy) mice. In Lin mice, the uterine levels of arachidonic acid (AA) and eicosapentaenoic acid (EPA) were 0.42 fold and 16 fold of those in Soy mice, respectively, with the EPA/AA ratio being 0.7 (vs 0.02 in Soy mice). Lin mice showed no alterations in any of the fertility indexes, including luteolysis and parturition. The uterine PG synthesis profiles of Lin mice were similar to those of Soy mice, but the levels of PGF2α and PGE2 were 50% of those in Soy mice, as a result of the increased EPA/AA ratio. PGF3α and PGE3 were undetectable in the uterine tissues of Soy and Lin mice. Interestingly, in Lin mice, 'luteolytic' PGF2α synthesis was considerably maintained even in the ω6 PUFA-reduced condition. These results suggest the existence of an elaborate mechanism securing PGF2α synthesis to a level that is sufficient for triggering luteolysis and parturition, even under ω6 PUFA-reduced conditions.
Collapse
Affiliation(s)
- Miho Hashimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Nagisa Makino
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Rina Yoshida
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Toshiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Soken Tsuchiya
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan.
| |
Collapse
|
8
|
Thomas BL, Guadagnin AR, Fehlberg LK, Sugimoto Y, Shinzato I, Drackley JK, Cardoso FC. Feeding rumen-protected lysine to dairy cows prepartum improves performance and health of their calves. J Dairy Sci 2021; 105:2256-2274. [PMID: 34955262 DOI: 10.3168/jds.2021-20545] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Accepted: 10/17/2021] [Indexed: 11/19/2022]
Abstract
Providing adequate concentrations of AA in the prepartum diet is pivotal for the cow's health and performance. However, less is known about the potential in utero effects of particular AA on early-life performance of calves. This experiment was conducted to determine the effects on dairy calves when their dams were fed rumen-protected lysine (RPL; AjiPro-L Generation 3, Ajinomoto Heartland Inc.; 0.54% dry matter of total mixed ration as top dress) from 26 ± 4.6 d (mean ± standard deviation) before calving until calving. Seventy-eight male (M) and female (F) Holstein calves were assigned to 2 treatments based on their dams' prepartum treatment, RPL supplementation (PRE-L) or without RPL (CON). At the time of birth (0.5-2 h after calving), before colostrum was fed, blood samples were collected. An initial body weight was obtained at 1 to 3 h after birth. Calves were fed 470 g of colostrum replacer (Land O'Lakes Bovine IgG Colostrum Replacer, Land O'Lakes, Inc.) diluted in 3.8 L of water. Calves were provided water ad libitum and fed milk replacer (Advance Excelerate, Milk Specialties Global Animal Nutrition; 28.5% crude protein, 15% fat) at 0600 h and 1700 h until 42 d of age. Calves were measured weekly, at weaning (d 42), and at the end of the experimental period (d 56). Plasma concentrations of AA were measured on d 0, 7, and 14 d using ultra-performance liquid chromatography-mass spectrometry (Waters) with a derivatization method (AccQ-Tag Derivatization). Final body weight was greater for M (87 ± 11 kg) than F (79 ± 7 kg). Calves in PRE-L tended to have greater dry matter (814 ± 3 g/d) and crude protein (234 ± 6 g/d) intakes than those in CON (793 ± 9 g/d and 228 ± 11 g/d, respectively). Calves in PRE-L had greater average daily gain (0.96 ± 0.04 kg/d) than calves in CON (0.85 ± 0.03 kg/d) during wk 6 to 8. Calves in PRE-L tended to be medicated fewer days than CON (4.7 ± 1.2 d vs. 6.2 ± 3.4 d, respectively). Calves in PRE-L-M and CON-F (2,916 ± 112 µM and 2,848 ± 112 µM, respectively) had greater total AA concentration in plasma than calves in PRE-L-F and CON-M (2,684 ± 112 µM and 2,582 ± 112 µM, respectively). Calves in PRE-L-F and CON-M (4.09 ± 0.11% and 4.16 ± 0.11%, respectively) had greater concentration of Lys as a percentage of total AA compared with calves in CON-F and PRE-L-M (3.91 ± 0.11% and 3.90 ± 0.11%, respectively). Calves in PRE-L tended to have greater percentage of phagocytic neutrophils (39.6 ± 1.59%) than calves in CON (35.9 ± 1.59%). In conclusion, increasing the metabolizable lysine provided to prepartum dairy cows had modest effect over offspring performance, with the major result being a greater average daily gain for calves in PRE-L during the preweaning phase (wk 6-8).
Collapse
Affiliation(s)
- B L Thomas
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - A R Guadagnin
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - L K Fehlberg
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - Y Sugimoto
- Ajinomoto Co. Inc., Tokyo, Japan 104-8315
| | - I Shinzato
- Ajinomoto Co. Inc., Tokyo, Japan 104-8315
| | - J K Drackley
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - F C Cardoso
- Department of Animal Sciences, University of Illinois, Urbana 61801.
| |
Collapse
|
9
|
Maeyama Y, Nakashima Y, Kato H, Hitora Y, Maki K, Inada N, Murakami S, Inazumi T, Ise Y, Sugimoto Y, Ishikawa H, Tsukamoto S. Amakusamine from a Psammocinia sp. Sponge: Isolation, Synthesis, and SAR Study on the Inhibition of RANKL-Induced Formation of Multinuclear Osteoclasts. J Nat Prod 2021; 84:2738-2743. [PMID: 34612636 DOI: 10.1021/acs.jnatprod.1c00758] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
A simple methylenedioxy dibromoindole alkaloid, amakusamine (1), was isolated from a marine sponge of the genus Psammocinia, and its structure was determined from spectroscopic data, time-dependent density-functional theory calculations, and synthesis. Compound 1 inhibited the receptor activator of nuclear factor-κB ligand (RANKL)-induced formation of multinuclear osteoclasts with an IC50 value of 10.5 μM in RAW264 cells. The structure-activity relationship of 1 was also investigated with synthetic derivatives.
Collapse
Affiliation(s)
- Yuka Maeyama
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Yuta Nakashima
- Graduate School of Science and Technology, Kumamoto University, Kumamoto 860-8555, Japan
| | - Hikaru Kato
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Yuki Hitora
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Kazuhiko Maki
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Natsumi Inada
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Shunya Murakami
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Yuji Ise
- Sesoko Station, University of the Ryukyus, 3422 Sesoko, Motobu, Okinawa 905-0227, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Hayato Ishikawa
- Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan
| | - Sachiko Tsukamoto
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| |
Collapse
|
10
|
Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Abbracchio MP, Alexander W, Al-Hosaini K, Bäck M, Barnes NM, Bathgate R, Beaulieu JM, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Boulay F, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Csaba Z, Dahlgren C, Dent G, Singh KD, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo EJ, Fong T, Fumagalli M, Gainetdinov RR, Gasparo MD, Gerard C, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay DL, Heinemann A, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kitazawa T, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Li XX, Williams TL, Lolait SJ, Lupp A, Macrae R, Maguire J, Mazella J, McArdle CA, Melmed S, Michel MC, Miller LJ, Mitolo V, Mouillac B, Müller CE, Murphy P, Nahon JL, Ngo T, Norel X, Nyimanu D, O'Carroll AM, Offermanns S, Panaro MA, Parmentier M, Pertwee RG, Pin JP, Prossnitz ER, Quinn M, Ramachandran R, Ray M, Reinscheid RK, Rondard P, Rovati GE, Ruzza C, Sanger GJ, Schöneberg T, Schulte G, Schulz S, Segaloff DL, Serhan CN, Stoddart LA, Sugimoto Y, Summers R, Tan VP, Thal D, Thomas WW, Timmermans PBMWM, Tirupula K, Tulipano G, Unal H, Unger T, Valant C, Vanderheyden P, Vaudry D, Vaudry H, Vilardaga JP, Walker CS, Wang JM, Ward DT, Wester HJ, Willars GB, Woodruff TM, Yao C, Ye RD. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors. Br J Pharmacol 2021; 178 Suppl 1:S27-S156. [PMID: 34529832 DOI: 10.1111/bph.15538] [Citation(s) in RCA: 296] [Impact Index Per Article: 98.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15538. G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
Collapse
Affiliation(s)
- Stephen Ph Alexander
- School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK
| | - Arthur Christopoulos
- Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia
| | | | - Eamonn Kelly
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK
| | - Alistair Mathie
- School of Engineering, Arts, Science and Technology, University of Suffolk, Ipswich, IP4 1QJ, UK
| | - John A Peters
- Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK
| | - Emma L Veale
- Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK
| | - Jane F Armstrong
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Elena Faccenda
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Simon D Harding
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Adam J Pawson
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Christopher Southan
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Jamie A Davies
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | | | | | | | - Magnus Bäck
- Karolinska University Hospital, Stockholm, Sweden
| | | | - Ross Bathgate
- Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
| | | | | | | | | | - Victoria Blaho
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | - Corinne Bousquet
- French Institute of Health and Medical Research(INSERM), Toulouse, France
| | | | | | | | | | | | | | | | | | - Bice Chini
- University of Milan Bicocca, Vedano al Lambro, Italy
| | - Jerold Chun
- University of California San Diego, La Jolla, USA
| | | | | | | | | | - Zsolt Csaba
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | | | | | - Pascal Dournaud
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | | | - Tung Fong
- Labcorp Drug Development, Somerset, USA
| | | | | | | | | | | | | | | | - Cyril Goudet
- French National Centre for Scientific Research, Montpellier, France
| | | | - Andrew L Gundlach
- Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
| | - Jörg Hamann
- Amsterdam University, Amsterdam, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Ralf Jockers
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | | | | | | | - Yasuyuki Kihara
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | | | | | | | | | | | | | - John D Lee
- University of Queensland, Brisbane, Australia
| | | | | | - Xaria X Li
- University of Queensland, Brisbane, Australia
| | | | | | - Amelie Lupp
- Friedrich Schiller University Jena, Jena, Germany
| | | | | | - Jean Mazella
- French National Centre for Scientific Research(CNRS), Valbonne, France
| | | | | | | | | | | | - Bernard Mouillac
- French National Centre for Scientific Research, Montpellier, France
| | | | | | - Jean-Louis Nahon
- French National Centre for Scientific Research(CNRS), Valbonne, France
| | - Tony Ngo
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | - Xavier Norel
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | - Stefan Offermanns
- Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
| | | | | | | | | | | | | | | | - Manisha Ray
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Thomas Unger
- Maastricht University, Maastricht, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Abbracchio MP, Alexander W, Al-Hosaini K, Bäck M, Barnes NM, Bathgate R, Beaulieu JM, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Boulay F, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Csaba Z, Dahlgren C, Dent G, Singh KD, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo EJ, Fong T, Fumagalli M, Gainetdinov RR, Gasparo MD, Gerard C, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay DL, Heinemann A, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kitazawa T, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Li XX, Williams TL, Lolait SJ, Lupp A, Macrae R, Maguire J, Mazella J, McArdle CA, Melmed S, Michel MC, Miller LJ, Mitolo V, Mouillac B, Müller CE, Murphy P, Nahon JL, Ngo T, Norel X, Nyimanu D, O'Carroll AM, Offermanns S, Panaro MA, Parmentier M, Pertwee RG, Pin JP, Prossnitz ER, Quinn M, Ramachandran R, Ray M, Reinscheid RK, Rondard P, Rovati GE, Ruzza C, Sanger GJ, Schöneberg T, Schulte G, Schulz S, Segaloff DL, Serhan CN, Stoddart LA, Sugimoto Y, Summers R, Tan VP, Thal D, Thomas WW, Timmermans PBMWM, Tirupula K, Tulipano G, Unal H, Unger T, Valant C, Vanderheyden P, Vaudry D, Vaudry H, Vilardaga JP, Walker CS, Wang JM, Ward DT, Wester HJ, Willars GB, Woodruff TM, Yao C, Ye RD. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors. Br J Pharmacol 2021; 178 Suppl 1:S27-S156. [PMID: 34529832 DOI: 10.1111/bph.15538/full] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023] Open
Abstract
The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15538. G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
Collapse
Affiliation(s)
- Stephen Ph Alexander
- School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK
| | - Arthur Christopoulos
- Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia
| | | | - Eamonn Kelly
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK
| | - Alistair Mathie
- School of Engineering, Arts, Science and Technology, University of Suffolk, Ipswich, IP4 1QJ, UK
| | - John A Peters
- Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK
| | - Emma L Veale
- Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK
| | - Jane F Armstrong
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Elena Faccenda
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Simon D Harding
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Adam J Pawson
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Christopher Southan
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | - Jamie A Davies
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK
| | | | | | | | - Magnus Bäck
- Karolinska University Hospital, Stockholm, Sweden
| | | | - Ross Bathgate
- Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
| | | | | | | | | | - Victoria Blaho
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | - Corinne Bousquet
- French Institute of Health and Medical Research(INSERM), Toulouse, France
| | | | | | | | | | | | | | | | | | - Bice Chini
- University of Milan Bicocca, Vedano al Lambro, Italy
| | - Jerold Chun
- University of California San Diego, La Jolla, USA
| | | | | | | | | | - Zsolt Csaba
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | | | | | - Pascal Dournaud
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | | | - Tung Fong
- Labcorp Drug Development, Somerset, USA
| | | | | | | | | | | | | | | | - Cyril Goudet
- French National Centre for Scientific Research, Montpellier, France
| | | | - Andrew L Gundlach
- Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
| | - Jörg Hamann
- Amsterdam University, Amsterdam, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Ralf Jockers
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | | | | | | | - Yasuyuki Kihara
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | | | | | | | | | | | | | - John D Lee
- University of Queensland, Brisbane, Australia
| | | | | | - Xaria X Li
- University of Queensland, Brisbane, Australia
| | | | | | - Amelie Lupp
- Friedrich Schiller University Jena, Jena, Germany
| | | | | | - Jean Mazella
- French National Centre for Scientific Research(CNRS), Valbonne, France
| | | | | | | | | | | | - Bernard Mouillac
- French National Centre for Scientific Research, Montpellier, France
| | | | | | - Jean-Louis Nahon
- French National Centre for Scientific Research(CNRS), Valbonne, France
| | - Tony Ngo
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | - Xavier Norel
- French Institute of Health and Medical Research(INSERM), Paris, France
| | | | | | - Stefan Offermanns
- Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
| | | | | | | | | | | | | | | | - Manisha Ray
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Thomas Unger
- Maastricht University, Maastricht, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
El-Desoky AHH, Inada N, Maeyama Y, Kato H, Hitora Y, Sebe M, Nagaki M, Kai A, Eguchi K, Inazumi T, Sugimoto Y, Frisvad JC, Williams RM, Tsukamoto S. Taichunins E-T, Isopimarane Diterpenes and a 20- nor-Isopimarane, from Aspergillus taichungensis (IBT 19404): Structures and Inhibitory Effects on RANKL-Induced Formation of Multinuclear Osteoclasts. J Nat Prod 2021; 84:2475-2485. [PMID: 34464116 DOI: 10.1021/acs.jnatprod.1c00486] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Fifteen new isopimarane-type diterpenes, taichunins E-S (1-15), and a new 20-nor-isopimarane, taichunin T (16), together with four known compounds were isolated from Aspergillus taichungensis (IBT 19404). The structures of these new compounds were determined by NMR and mass spectroscopy, and their absolute configurations were analyzed by NOESY and TDDFT calculations of ECD spectra. Taichunins G, K, and N (3, 7, and 10) completely inhibited the receptor activator of nuclear factor-κB ligand (RANKL)-induced formation of multinuclear osteoclasts in RAW264 cells at 5 μM, with 3 showing 92% inhibition at a concentration of 0.2 μM.
Collapse
Affiliation(s)
- Ahmed H H El-Desoky
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
- Pharmaceutical Industries Research Division, Pharmacognosy Department, National Research Centre, 33 El Bohouth Street (Former El Tahrir Street), Dokki, P.O. 12622, Giza, Egypt
| | - Natsumi Inada
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Yuka Maeyama
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Hikaru Kato
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Yuki Hitora
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Momona Sebe
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Mika Nagaki
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Aika Kai
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Keisuke Eguchi
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| | - Jens C Frisvad
- Section for Synthetic Biology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Soltofts Plads Building 221, 2800 Kongens Lyngby, Denmark
| | - Robert M Williams
- Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, Colorado 80523, United States
| | - Sachiko Tsukamoto
- Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
| |
Collapse
|
13
|
Koga T, Sasaki F, Saeki K, Tsuchiya S, Okuno T, Ohba M, Ichiki T, Iwamoto S, Uzawa H, Kitajima K, Meno C, Nakamura E, Tada N, Fukui Y, Kikuta J, Ishii M, Sugimoto Y, Nakao M, Yokomizo T. Expression of leukotriene B 4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation. Cell Mol Immunol 2021; 18:1437-1449. [PMID: 33037399 PMCID: PMC8167169 DOI: 10.1038/s41423-020-00559-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 09/10/2020] [Accepted: 09/11/2020] [Indexed: 11/25/2022] Open
Abstract
Leukotriene B4 (LTB4) receptor 1 (BLT1) is a chemotactic G protein-coupled receptor expressed by leukocytes, such as granulocytes, macrophages, and activated T cells. Although there is growing evidence that BLT1 plays crucial roles in immune responses, its role in dendritic cells remains largely unknown. Here, we identified novel DC subsets defined by the expression of BLT1, namely, BLT1hi and BLT1lo DCs. We also found that BLT1hi and BLT1lo DCs differentially migrated toward LTB4 and CCL21, a lymph node-homing chemoattractant, respectively. By generating LTB4-producing enzyme LTA4H knockout mice and CD11c promoter-driven Cre recombinase-expressing BLT1 conditional knockout (BLT1 cKO) mice, we showed that the migration of BLT1hi DCs exacerbated allergic contact dermatitis. Comprehensive transcriptome analysis revealed that BLT1hi DCs preferentially induced Th1 differentiation by upregulating IL-12p35 expression, whereas BLT1lo DCs accelerated T cell proliferation by producing IL-2. Collectively, the data reveal an unexpected role for BLT1 as a novel DC subset marker and provide novel insights into the role of the LTB4-BLT1 axis in the spatiotemporal regulation of distinct DC subsets.
Collapse
Affiliation(s)
- Tomoaki Koga
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
- Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, 860-0811, Japan
| | - Fumiyuki Sasaki
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
- Department of Cell Signaling, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan
| | - Kazuko Saeki
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Soken Tsuchiya
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Toshiaki Okuno
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Mai Ohba
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Takako Ichiki
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Satoshi Iwamoto
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Hirotsugu Uzawa
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Keiko Kitajima
- Department of Developmental Biology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan
| | - Chikara Meno
- Department of Developmental Biology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan
| | - Eri Nakamura
- Laboratory of Genome Research, Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Norihiro Tada
- Laboratory of Genome Research, Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
| | - Yoshinori Fukui
- Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan
| | - Junichi Kikuta
- Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Osaka, 565-0871, Japan
| | - Masaru Ishii
- Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Osaka, 565-0871, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan
| | - Mitsuyoshi Nakao
- Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, 860-0811, Japan
| | - Takehiko Yokomizo
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.
| |
Collapse
|
14
|
Miyamoto M, Sugimoto Y, Nishijima D, Baldwin M, Doerner R, Zaloznik A, Kim J, Nakamichi M. Comparative study of surface modification and D retention between beryllium and beryllides under high flux plasma exposure. Nuclear Materials and Energy 2021. [DOI: 10.1016/j.nme.2021.101014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
15
|
Sekine R, Hirata M, Ikezoe R, Jang S, Kubota Y, Kayano H, Sugata K, Aizawa T, Noguchi D, Kim D, Sugimoto Y, Matsuura R, Yamazaki H, Ichimura M, Yoshikawa M, Kohagura J, Nakashima Y, Ezumi N, Sakamoto M. Measurement of axial phase difference of density fluctuations owing to spontaneously excited waves by using microwave reflectometer on GAMMA 10/PDX. Rev Sci Instrum 2021; 92:053506. [PMID: 34243319 DOI: 10.1063/5.0043821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2021] [Accepted: 04/14/2021] [Indexed: 06/13/2023]
Abstract
In the GAMMA 10/PDX tandem mirror, plasma with strong ion-temperature anisotropy is produced by using the ion cyclotron range of frequency waves. This anisotropy of ion temperature causes several Alfvén-Ion-Cyclotron (AIC) waves to spontaneously excite in the frequency range just below the ion cyclotron frequency. In addition, difference-frequency (DF) waves are excited in the radial inner region of the plasma by wave-wave coupling among the AIC waves. The radial density profiles were measured at multi-axial positions using a frequency-modulation reflectometer with an axial array of microwave antennas, and an axial variation of the density was found to be significant. In addition, a relative phase difference of the DF wave between axially separated two points was first obtained by finely choosing the probing frequency of the reflectometers with a maximum coherence used as a measure, indicating that the DF wave is a propagating wave, while the pump AIC waves are standing waves in the axial region of measurement.
Collapse
Affiliation(s)
- R Sekine
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - M Hirata
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - R Ikezoe
- Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - S Jang
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - Y Kubota
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - H Kayano
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - K Sugata
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - T Aizawa
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - D Noguchi
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - D Kim
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - Y Sugimoto
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - R Matsuura
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - H Yamazaki
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - M Ichimura
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - M Yoshikawa
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - J Kohagura
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - Y Nakashima
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - N Ezumi
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| | - M Sakamoto
- Plasma Research Center, University of Tsukuba, Tsukuba 305-8577, Japan
| |
Collapse
|
16
|
Suchiva P, Takai T, Kamijo S, Maruyama N, Yokomizo T, Sugimoto Y, Okumura K, Ikeda S, Ogawa H. Inhibition of Both Cyclooxygenase-1 and -2 Promotes Epicutaneous Th2 and Th17 Sensitization and Allergic Airway Inflammation on Subsequent Airway Exposure to Protease Allergen in Mice. Int Arch Allergy Immunol 2021; 182:788-799. [PMID: 33873179 DOI: 10.1159/000514975] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Accepted: 01/30/2021] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION Epicutaneous (e.c.) allergen exposure is an important route of sensitization toward allergic diseases in the atopic march. Allergen sources such as house dust mites contain proteases that involve in the pathogenesis of allergy. Prostanoids produced via pathways downstream of cyclooxygenases (COXs) regulate immune responses. Here, we demonstrate effects of COX inhibition with nonsteroidal anti-inflammatory drugs (NSAIDs) on e.c. sensitization to protease allergen and subsequent airway inflammation in mice. METHODS Mice were treated with NSAIDs during e.c. sensitization to a model protease allergen, papain, and/or subsequent intranasal challenge with low-dose papain. Serum antibodies, cytokine production in antigen-restimulated skin or bronchial draining lymph node (DLN) cells, and airway inflammation were analyzed. RESULTS In e.c. sensitization, treatment with a nonspecific COX inhibitor, indomethacin, promoted serum total and papain-specific IgE response and Th2 and Th17 cytokine production in skin DLN cells. After intranasal challenge, treatment with indomethacin promoted allergic airway inflammation and Th2 and Th17 cytokine production in bronchial DLN cells, which depended modestly or largely on COX inhibition during e.c. sensitization or intranasal challenge, respectively. Co-treatment with COX-1-selective and COX-2-selective inhibitors promoted the skin and bronchial DLN cell Th cytokine responses and airway inflammation more efficiently than treatment with either selective inhibitor. CONCLUSION The results suggest that the overall effects of COX downstream prostanoids are suppressive for development and expansion of not only Th2 but also, unexpectedly, Th17 upon exposure to protease allergens via skin or airways and allergic airway inflammation.
Collapse
Affiliation(s)
- Punyada Suchiva
- Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.,Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Toshiro Takai
- Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Seiji Kamijo
- Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Natsuko Maruyama
- Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Takehiko Yokomizo
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Kumamoto University Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Ko Okumura
- Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Shigaku Ikeda
- Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.,Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Hideoki Ogawa
- Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan
| |
Collapse
|
17
|
Razali N, Hohjoh H, Inazumi T, Maharjan BD, Nakagawa K, Konishi M, Sugimoto Y, Hasegawa H. Induced Prostanoid Synthesis Regulates the Balance between Th1- and Th2-Producing Inflammatory Cytokines in the Thymus of Diet-Restricted Mice. Biol Pharm Bull 2020; 43:649-662. [PMID: 32238706 DOI: 10.1248/bpb.b19-00838] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Multiple external and internal factors have been reported to induce thymic involution. Involution involves dramatic reduction in size and function of the thymus, leading to various immunodeficiency-related disorders. Therefore, clarifying and manipulating molecular mechanisms governing thymic involution are clinically important, although only a few studies have dealt with this issue. In the present study, we investigated the molecular mechanisms underlying thymic involution using a murine acute diet-restriction model. Gene expression analyses indicated that the expression of T helper 1 (Th1)-producing cytokines, namely interferon-γ and interleukin (IL)-2, was down-regulated, while that of Th2-producing IL-5, IL-6, IL-10 and IL-13 was up-regulated, suggesting that acute diet-restriction regulates the polarization of naïve T cells to a Th2-like phenotype during thymic involution. mRNAs for prostanoid biosynthetic enzymes were up-regulated by acute diet-restriction. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses detected the increased production of prostanoids, particularly prostaglandin D2 and thromboxane B2, a metabolite of thromboxane A2, in the diet-restricted thymus. Administration of non-steroidal anti-inflammatory drugs, namely aspirin and etodolac, to inhibit prostanoid synthesis suppressed the biased expression of Th1- and Th2-cytokines as well as molecular markers of Th1 and Th2 cells in the diet-restricted thymus, without affecting the reduction of thymus size. In vitro stimulation of thymocytes with phorbol myristate acetate (PMA)/ionomycin confirmed the polarization of thymocytes from diet-restricted mice toward Th2 cells. These results indicated that the induced production of prostanoids during diet-restriction-induced thymic involution is involved in the polarization of naïve T cells in the thymus.
Collapse
Affiliation(s)
| | - Hirofumi Hohjoh
- Laboratory of Hygienic Sciences, Kobe Pharmaceutical University
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University
| | | | - Kimie Nakagawa
- Laboratory of Hygienic Sciences, Kobe Pharmaceutical University
| | | | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University
| | | |
Collapse
|
18
|
Fehlberg LK, Guadagnin AR, Thomas BL, Sugimoto Y, Shinzato I, Cardoso FC. Feeding rumen-protected lysine prepartum increases energy-corrected milk and milk component yields in Holstein cows during early lactation. J Dairy Sci 2020; 103:11386-11400. [PMID: 33041036 DOI: 10.3168/jds.2020-18542] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Accepted: 07/23/2020] [Indexed: 01/11/2023]
Abstract
Feeding rumen-protected Lys (RPL) may be used to increase lactation performance in dairy cows; however, the effect of feeding RPL during the prepartum period and subsequent effect on postpartum performance is not well explored. Therefore, this experiment was conducted to determine the effects of feeding RPL (AjiPro-L Generation 3, Ajinomoto Heartland Inc., Chicago, IL) prepartum, postpartum, or both on performance, health, and blood metabolites. Seventy-five multiparous Holstein cows, blocked by parity, previous 305-d mature-equivalent milk production, expected calving date, and body condition score during the far-off dry period were assigned to 1 of 2 dietary treatments: total mixed ration with or without RPL in a randomized, complete block design. A 2 × 2 factorial arrangement of treatments was used. Prepartum (-28 d to calving), animals were fed a diet (forage, 68% of dietary DM) with RPL [PRE-L; 0.54% RPL of dietary dry matter intake (DMI)] or without RPL (control; PRE-C). After calving, half of the cows from each prepartum treatment group were assigned to a diet (forage, 55.5% of dietary DM) with RPL (PRE-L POST-L; PRE-C POST-L; 0.40% RPL of dietary DMI) or without RPL (PRE-C POST-C; PRE-L POST-C) until d 28 postpartum. Cows were milked twice a day and milk samples were taken on 7 ± 1.3, 14 ± 1.4, and 28 ± 1.1 d relative to calving (DRC). Milk yield and DMI were recorded daily. Blood samples were taken for plasma AA analysis on -7 ± 0.5, 0 ± 0.5, 7 ± 0.9, and 14 ± 0.9 DRC. Cows in PRE-L had greater body weight at -2 and -1 wk before calving compared with those in PRE-C, though body weight change from wk -4 to -1 was not different. Body weight (717 ± 6 kg) was greater and DMI (18.1 ± 0.7 kg) tended to be greater for cows in PRE-L POST-L and PRE-L POST-C compared with those that were in PRE-C POST-L and PRE-C POST-C (707 ± 6 and 16.8 ± 0.7 kg, respectively). Energy-corrected milk (48.8 ± 1.9 kg/d), milk fat (1.9 ± 0.1 kg/d), milk true protein (1.4 ± 0.1 kg/d), milk casein (0.6 ± 0.04 kg/d), and milk lactose yields (2.1 ± 0.1 kg/d) were greater for cows in PRE-L POST-L and PRE-L POST-C compared with those that were in PRE-C POST-L and PRE-C POST-C (44.2 ± 1.9, 1.7 ± 0.1, 1.3 ± 0.1, 0.5 ± 0.04, 1.9 ± 0.1 kg/d, respectively). Plasma concentrations of Lys prepartum (69.8 ± 1.8 µM) increased for cows in PRE-L compared with those in PRE-C (62.5 ± 1.3 µM). In conclusion, RPL consumed prepartum tended to increase postpartum DMI and increased energy-corrected milk and milk component yields. This indicates that prepartum supply of intestinally available Lys is pertinent to postpartum performance. However, postpartum supply of intestinally available Lys had no effect on cows' performance.
Collapse
Affiliation(s)
- L K Fehlberg
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - A R Guadagnin
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - B L Thomas
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | | | | | - F C Cardoso
- Department of Animal Sciences, University of Illinois, Urbana 61801.
| |
Collapse
|
19
|
Norel X, Sugimoto Y, Ozen G, Abdelazeem H, Amgoud Y, Bouhadoun A, Bassiouni W, Goepp M, Mani S, Manikpurage HD, Senbel A, Longrois D, Heinemann A, Yao C, Clapp LH. International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E 2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions. Pharmacol Rev 2020; 72:910-968. [PMID: 32962984 PMCID: PMC7509579 DOI: 10.1124/pr.120.019331] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Prostaglandins are derived from arachidonic acid metabolism through cyclooxygenase activities. Among prostaglandins (PGs), prostacyclin (PGI2) and PGE2 are strongly involved in the regulation of homeostasis and main physiologic functions. In addition, the synthesis of these two prostaglandins is significantly increased during inflammation. PGI2 and PGE2 exert their biologic actions by binding to their respective receptors, namely prostacyclin receptor (IP) and prostaglandin E2 receptor (EP) 1-4, which belong to the family of G-protein-coupled receptors. IP and EP1-4 receptors are widely distributed in the body and thus play various physiologic and pathophysiologic roles. In this review, we discuss the recent advances in studies using pharmacological approaches, genetically modified animals, and genome-wide association studies regarding the roles of IP and EP1-4 receptors in the immune, cardiovascular, nervous, gastrointestinal, respiratory, genitourinary, and musculoskeletal systems. In particular, we highlight similarities and differences between human and rodents in terms of the specific roles of IP and EP1-4 receptors and their downstream signaling pathways, functions, and activities for each biologic system. We also highlight the potential novel therapeutic benefit of targeting IP and EP1-4 receptors in several diseases based on the scientific advances, animal models, and human studies. SIGNIFICANCE STATEMENT: In this review, we present an update of the pathophysiologic role of the prostacyclin receptor, prostaglandin E2 receptor (EP) 1, EP2, EP3, and EP4 receptors when activated by the two main prostaglandins, namely prostacyclin and prostaglandin E2, produced during inflammatory conditions in human and rodents. In addition, this comparison of the published results in each tissue and/or pathology should facilitate the choice of the most appropriate model for the future studies.
Collapse
Affiliation(s)
- Xavier Norel
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Yukihiko Sugimoto
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Gulsev Ozen
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Heba Abdelazeem
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Yasmine Amgoud
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Amel Bouhadoun
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Wesam Bassiouni
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Marie Goepp
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Salma Mani
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Hasanga D Manikpurage
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Amira Senbel
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Dan Longrois
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Akos Heinemann
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Chengcan Yao
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| | - Lucie H Clapp
- Université de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), UMR-S 1148, CHU X. Bichat, Paris, France (X.N., G.O., H.A., Y.A., A.B., S.M., H.D.M., A.S., D.L.); Université Sorbonne Paris Nord, Villetaneuse, France (X.N., H.A., Y.A., A.B., S.M., D.L.); Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan (Y.S.); Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey (G.O.); Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (A.S., H.A., W.B.); Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom (C.Y., M.G.); Institut Supérieur de Biotechnologie de Monastir (ISBM), Université de Monastir, Monastir, Tunisia (S.M.); CHU X. Bichat, AP-HP, Paris, France (D.L.); Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria (A.H.); and Centre for Cardiovascular Physiology & Pharmacology, University College London, London, United Kingdom (L.H.C.)
| |
Collapse
|
20
|
Inazumi T, Yamada K, Shirata N, Sato H, Taketomi Y, Morita K, Hohjoh H, Tsuchiya S, Oniki K, Watanabe T, Sasaki Y, Oike Y, Ogata Y, Saruwatari J, Murakami M, Sugimoto Y. Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance. Cell Rep 2020; 33:108265. [DOI: 10.1016/j.celrep.2020.108265] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2019] [Revised: 09/10/2020] [Accepted: 09/22/2020] [Indexed: 12/24/2022] Open
|
21
|
Breyer RM, Clapp L, Coleman RA, Giembycz M, Heinemann A, Hills R, Jones RL, Narumiya S, Norel X, Pettipher R, Sugimoto Y, Uddin M, Woodward DF, Yao C. Prostanoid receptors (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database. ACTA ACUST UNITED AC 2020. [DOI: 10.2218/gtopdb/f58/2020.4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Prostanoid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Prostanoid Receptors [661]) are activated by the endogenous ligands prostaglandins PGD2, PGE1, PGE2 , PGF2α, PGH2, prostacyclin [PGI2] and thromboxane A2. Differences and similarities between human and rodent prostanoid receptor orthologues, and their specific roles in pathophysiologic conditions are reviewed in [423]. Measurement of the potency of PGI2 and thromboxane A2 is hampered by their instability in physiological salt solution; they are often replaced by cicaprost and U46619, respectively, in receptor characterization studies.
Collapse
|
22
|
Kawakami N, Iwata K, Shiotari A, Sugimoto Y. Intrinsic reconstruction of ice-I surfaces. Sci Adv 2020; 6:6/37/eabb7986. [PMID: 32917710 PMCID: PMC7486089 DOI: 10.1126/sciadv.abb7986] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Accepted: 07/24/2020] [Indexed: 06/11/2023]
Abstract
Understanding the precise atomic structure of ice surfaces is critical for revealing the mechanisms of physical and chemical phenomena at the surfaces, such as ice growth, melting, and chemical reactions. Nevertheless, no conclusive structure has been established. In this study, noncontact atomic force microscopy was used to address the characterization of the atomic structures of ice Ih(0001) and Ic(111) surfaces. The topmost hydrogen atoms are arranged with a short-range (2 × 2) order, independent of the ice thickness and growth substrates used. The electrostatic repulsion between non-hydrogen-bonded water molecules at the surface causes a reduction in the number of the topmost hydrogen atoms together with a distortion of the ideal honeycomb arrangement of water molecules, leading to a short-range-ordered surface reconstruction.
Collapse
Affiliation(s)
- N Kawakami
- Department of Advanced Materials Science, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - K Iwata
- Department of Advanced Materials Science, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - A Shiotari
- Department of Advanced Materials Science, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - Y Sugimoto
- Department of Advanced Materials Science, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561, Japan.
| |
Collapse
|
23
|
Imafuku T, Watanabe H, Satoh T, Matsuzaka T, Inazumi T, Kato H, Tanaka S, Nakamura Y, Nakano T, Tokumaru K, Maeda H, Mukunoki A, Takeo T, Nakagata N, Tanaka M, Matsushita K, Tsuchiya S, Sugimoto Y, Shimano H, Fukagawa M, Maruyama T. Advanced Oxidation Protein Products Contribute to Renal Tubulopathy via Perturbation of Renal Fatty Acids. ACTA ACUST UNITED AC 2020; 1:781-796. [DOI: 10.34067/kid.0000772019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2019] [Accepted: 06/01/2020] [Indexed: 11/27/2022]
Abstract
BackgroundRenal proximal tubulopathy plays a crucial role in kidney disease, but its molecular mechanism is incompletely understood. Because proximal tubular cells consume a lot of energy during reabsorption, the relationship between fatty acids (FAs) and proximal tubulopathy has been attracting attention. The purpose of this study is to investigate the association between change in renal FA composition and tubulopathy.MethodsMice with cisplatin-induced nephrotoxicity were used as a model of AKI and 5/6-nephrectomized mice were used as a model of CKD. Renal FA composition in mice was measured by GC-MS. Human tubular epithelial cells (HK-2 cells) were used for in vitro studies.ResultsIn kidneys of AKI mice, increased stearic acid (C18:0) and decreased palmitic acid (C16:0) were observed, accompanied by increased expression of the long-chain FA elongase Elovl6. Similar results were also obtained in CKD mice. We show that C18:0 has higher tubular toxicity than C16:0 via induction of ER stress. Using adenovirus-expressing Elovl6 or siRNA for Elovl6 in HK-2 cells, we demonstrated that increased Elovl6 expression contributes to tubulopathy via increasing C18:0. Elovl6 knockout suppressed the increased serum creatinine levels, renal ER stress, and inflammation that would usually result after 5/6 nephrectomy. Advanced oxidation protein products (AOPPs), specifically an oxidized albumin, was found to induce Elovl6 via the mTORC1/SREBP1 pathway.ConclusionsAOPPs may contribute to renal tubulopathy via perturbation of renal FAs through induction of Elovl6. The perturbation of renal FAs induced by the AOPPs-Elovl6 system could be a potential target for the treatment of tubulopathy.
Collapse
|
24
|
Sugimoto Y, Yamamoto T, Aoki R, Nakano H, Takayama M. CLINICAL STUDY OF COPD CASES USING A COPD SCREENING QUESTIONNAIRE. Chest 2020. [DOI: 10.1016/j.chest.2020.05.332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
25
|
Tsuge K, Inazumi T, Shimamoto A, Sugimoto Y. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. Int Immunol 2020; 31:597-606. [PMID: 30926983 DOI: 10.1093/intimm/dxz021] [Citation(s) in RCA: 128] [Impact Index Per Article: 32.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2018] [Accepted: 03/18/2019] [Indexed: 01/12/2023] Open
Abstract
Prostaglandins (PGs) are the major lipid mediators in animals and which are biosynthesized from arachidonic acid by the cyclooxygenases (COX-1 or COX-2) as the rate-limiting enzymes. Prostaglandin E2 (PGE2), which is the most abundantly detected PG in various tissues, exerts versatile physiological and pathological actions via four receptor subtypes (EP1-4). Non-steroidal anti-inflammatory drugs, such as aspirin and indomethacin, exert potent anti-inflammatory actions by the inhibition of COX activity and the resulting suppression of PG production. Therefore, PGE2 has been shown to exacerbate several inflammatory responses and immune diseases. Recently, studies using mice deficient in each PG receptor subtype have clarified the detailed mechanisms underlying PGE2-associated inflammation and autoimmune diseases involving each EP receptor. Here, we review the recent advances in our understanding of the roles of PGE2 receptors in the progression of acute and chronic inflammation and autoimmune diseases. PGE2 induces acute inflammation through mast cell activation via the EP3 receptor. PGE2 also induces chronic inflammation and various autoimmune diseases through T helper 1 (Th1)-cell differentiation, Th17-cell proliferation and IL-22 production from Th22 cells via the EP2 and EP4 receptors. The possibility of EP receptor-targeted drug development for the treatment of immune diseases is also discussed.
Collapse
Affiliation(s)
- Kyoshiro Tsuge
- Department of Regenerative Medicine Research, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi, Japan
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.,Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology, Chiyoda-ku, Tokyo, Japan
| | - Akira Shimamoto
- Department of Regenerative Medicine Research, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.,Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology, Chiyoda-ku, Tokyo, Japan
| |
Collapse
|
26
|
Ishihara E, Nagaoka Y, Okuno T, Kofuji S, Ishigami-Yuasa M, Kagechika H, Kamimura K, Terai S, Yokomizo T, Sugimoto Y, Fujita Y, Suzuki A, Nishina H. Prostaglandin E 2 and its receptor EP2 trigger signaling that contributes to YAP-mediated cell competition. Genes Cells 2020; 25:197-214. [PMID: 31989743 PMCID: PMC7078805 DOI: 10.1111/gtc.12750] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2020] [Revised: 01/20/2020] [Accepted: 01/21/2020] [Indexed: 12/28/2022]
Abstract
Cell competition is a biological process by which unfit cells are eliminated from “cell society.” We previously showed that cultured mammalian epithelial Madin‐Darby canine kidney (MDCK) cells expressing constitutively active YAP were eliminated by apical extrusion when surrounded by “normal” MDCK cells. However, the molecular mechanism underlying the elimination of active YAP‐expressing cells was unknown. Here, we used high‐throughput chemical compound screening to identify cyclooxygenase‐2 (COX‐2) as a key molecule triggering cell competition. Our work shows that COX‐2‐mediated PGE2 secretion engages its receptor EP2 on abnormal and nearby normal cells. This engagement of EP2 triggers downstream signaling via an adenylyl cyclase‐cyclic AMP‐PKA pathway that, in the presence of active YAP, induces E‐cadherin internalization leading to apical extrusion. Thus, COX‐2‐induced PGE2 appears a warning signal to both abnormal and surrounding normal cells to drive cell competition.
Collapse
Affiliation(s)
- Erika Ishihara
- Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Yuya Nagaoka
- Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Toshiaki Okuno
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Satoshi Kofuji
- Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Mari Ishigami-Yuasa
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Hiroyuki Kagechika
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Kenya Kamimura
- Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
| | - Shuji Terai
- Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
| | - Takehiko Yokomizo
- Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Yasuyuki Fujita
- Division of Molecular Oncology, Institute for Genetic Medicine, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo, Japan
| | - Akira Suzuki
- Division of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Hiroshi Nishina
- Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| |
Collapse
|
27
|
Yamamoto Y, Taniguchi T, Inazumi T, Iwamura R, Yoneda K, Odani-Kawabata N, Matsugi T, Sugimoto Y, Shams NK. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells. J Ocul Pharmacol Ther 2020; 36:162-169. [PMID: 31934812 PMCID: PMC7175626 DOI: 10.1089/jop.2019.0079] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Purpose: We aimed at comparing the effects of omidenepag (OMD) with those of prostaglandin F (FP) receptor agonists (FP agonists) on adipogenesis in mouse 3T3-L1 cells. Methods: To evaluate the agonistic activities of OMD against the mouse EP2 (mEP2) receptor, we determined cAMP contents in mEP2 receptor-expressing CHO cells by using radioimmunoassays. Overall, 3T3-L1 cells were cultured in differentiation medium for 10 days and adipocyte differentiation was assessed according to Oil Red O-stained cell areas. Changes in expression levels of the adipogenic transcription factors Pparg, Cebpa, and Cebpb were determined by using real-time polymerase chain reaction (PCR). OMD at 0.1, 1, 10, and 40 μmol/L, latanoprost free acid (LAT-A) at 0.1 μmol/L, or prostaglandin F2α (PGF2α), at 0.1 μmol/L were added to cell culture media during adipogenesis. Oil Red O-stained areas and expression patterns of transcription factor targets of OMD or FP agonists were compared with those of untreated controls. Results: The 50% effective concentration (EC50) of OMD against the mEP2 receptor was 3.9 nmol/L. Accumulations of Oil Red O-stained lipid droplets were observed inside control cells on day 10. LAT-A and PGF2α significantly inhibited the accumulation of lipid droplets; however, OMD had no effect on this process even at concentrations up to 40 μmol/L. LAT-A and PGF2α significantly suppressed Pparg, Cebpa, and Cebpb gene expression levels during adipocyte differentiation. Conversely, OMD had no obvious effects on the expression levels of these genes. Conclusions: A selective EP2 receptor agonist, OMD, did not affect the adipocyte differentiation in 3T3-L1 cells, whereas FP agonists significantly inhibited this process.
Collapse
Affiliation(s)
- Yasuko Yamamoto
- Research and Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan
| | - Takazumi Taniguchi
- Research and Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Ryo Iwamura
- Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan
| | - Kenji Yoneda
- Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan
| | - Noriko Odani-Kawabata
- Research and Development Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan.,Research and Development Division, Santen, Inc., Emeryville, California
| | - Takeshi Matsugi
- Research and Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Naveed K Shams
- Research and Development Division, Santen, Inc., Emeryville, California
| |
Collapse
|
28
|
Yoshida M, Takayanagi Y, Ichino-Yamashita A, Sato K, Sugimoto Y, Kimura T, Nishimori K. Functional Hierarchy of Uterotonics Required for Successful Parturition in Mice. Endocrinology 2019; 160:2800-2810. [PMID: 31517984 PMCID: PMC6887699 DOI: 10.1210/en.2019-00499] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Accepted: 09/09/2019] [Indexed: 11/23/2022]
Abstract
Parturition is an essential process in placental mammals for giving birth to offspring. However, the molecular machineries of parturition are not fully understood. We investigated whether oxytocin plays a crucial role in the progress of parturition in cooperation with the prostaglandin F2α (PGF2α) receptor. We first examined alterations in the expression of uterine contraction-associated genes in uteri of oxytocin receptor-deficient mice (Oxtr-/-) during parturition. We found that induction of cyclooxygenase (COX)-2 and connexin 43 expression was impaired in Oxtr-/-, whereas that of PGF2α receptor expression was not. We next generated mice with double knockout of genes for the oxytocin receptor/oxytocin and PGF2α receptor (Oxtr-/-;Ptgfr-/- and Oxt-/-;Ptgfr-/-) and evaluated their parturition with Oxtr-/-, Oxt-/-, Ptgfr-/-, and wild-type mice. In Oxtr-/-;Ptgfr-/- and Oxt-/-;Ptgfr-/-, pregnancy rates were similar to those of other genotypes. However, normal parturition was not observed in Oxtr-/-;Ptgfr-/- or Oxt-/-;Ptgfr-/- because of persistent progesterone from the corpus luteum, as observed in Ptgfr-/-. We administered RU486, a progesterone antagonist, to Ptgfr-/-, Oxtr-/-;Ptgfr-/-, and Oxt-/-;Ptgfr-/- on gestation day 19. These mice were able to deliver a living first pup and the parturition onset was similar to that in Ptgfr-/-. Meanwhile, unlike Ptgfr-/-, ∼75% of Oxtr-/-;Ptgfr-/- and Oxt-/-;Ptgfr-/- administered RU486 remained in labor at 24 hours after the onset of parturition. All of the pups that experienced prolonged labor died. We thus revealed that the oxytocin receptor is an upstream regulator of COX-2 and connexin 43 in the uterus during parturition and that both oxytocin/oxytocin receptor and PGF2α receptor are major components for successful parturition.
Collapse
Affiliation(s)
- Masahide Yoshida
- Laboratory of Molecular Biology, Department of Molecular and Cell Biology, Graduate School of Agricultural Science, Tohoku University, Sendai-shi, Miyagi-ken, Japan
- Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke-shi, Tochigi-ken, Japan
| | - Yuki Takayanagi
- Laboratory of Molecular Biology, Department of Molecular and Cell Biology, Graduate School of Agricultural Science, Tohoku University, Sendai-shi, Miyagi-ken, Japan
- Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke-shi, Tochigi-ken, Japan
| | - Azusa Ichino-Yamashita
- Laboratory of Molecular Biology, Department of Molecular and Cell Biology, Graduate School of Agricultural Science, Tohoku University, Sendai-shi, Miyagi-ken, Japan
| | - Kei Sato
- Laboratory of Molecular Biology, Department of Molecular and Cell Biology, Graduate School of Agricultural Science, Tohoku University, Sendai-shi, Miyagi-ken, Japan
- Division of Systems Virology, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo-to, Japan
- CREST, Japan Science and Technology Agency, Kawaguchi-shi, Saitama-ken, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-Ku, Kumamoto-ken, Japan
| | - Tadashi Kimura
- Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita-shi, Osaka-hu, Japan
| | - Katsuhiko Nishimori
- Laboratory of Molecular Biology, Department of Molecular and Cell Biology, Graduate School of Agricultural Science, Tohoku University, Sendai-shi, Miyagi-ken, Japan
- Department of Obesity and Inflammation Research, Fukushima Medical University, Fukushima-shi, Fukushima-ken, Japan
- Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University, Fukushima-shi, Fukushima-ken, Japan
- Correspondence: Katsuhiko Nishimori, PhD, Department of Obesity and Inflammation Research, Fukushima Medical University, 1 Hikarigaoka, Fukushima-shi, Fukushima-ken 960-1295, Japan. E-mail:
| |
Collapse
|
29
|
Breyer RM, Clapp L, Coleman RA, Giembycz M, Heinemann A, Hills R, Jones RL, Narumiya S, Norel X, Pettipher R, Sugimoto Y, Uddin M, Woodward DF, Yao C. Prostanoid receptors (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database. ACTA ACUST UNITED AC 2019. [DOI: 10.2218/gtopdb/f58/2019.5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Prostanoid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Prostanoid Receptors [659]) are activated by the endogenous ligands prostaglandins PGD2, PGE1, PGE2 , PGF2α, PGH2, prostacyclin [PGI2] and thromboxane A2. Measurement of the potency of PGI2 and thromboxane A2 is hampered by their instability in physiological salt solution; they are often replaced by cicaprost and U46619, respectively, in receptor characterization studies.
Collapse
|
30
|
Isshiki H, Kondou K, Takizawa S, Shimose K, Kawabe T, Minamitani E, Yamaguchi N, Ishii F, Shiotari A, Sugimoto Y, Miwa S, Otani Y. Realization of Spin-dependent Functionality by Covering a Metal Surface with a Single Layer of Molecules. Nano Lett 2019; 19:7119-7123. [PMID: 31429575 DOI: 10.1021/acs.nanolett.9b02619] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
An interface of molecule and metal has attracted much attention in the research field of nanoelectronics because of their high degree of design freedom. Here, we demonstrate an efficient spin-to-charge current conversion at the metal surface covered by a single layer of molecules. Spin currents are injected into an interface between metal (Cu) and lead(II) phthalocyanine by means of the spin pumping method. An observed voltage signal is caused by the inverse Edelstein effect, i.e., spin-to-charge current conversion at the interface. The conversion coefficient, inverse Edelstein length, is estimated to be 0.40 ± 0.06 nm, comparable with the largest Rashba spin splitting of interfaces with heavy metals. Interestingly, the Edelstein length strongly depends on the thickness of the molecule and takes a maximum value when a single layer of molecules is formed on the Cu surface. Comparative analysis between scanning probe microscopy and first-principles calculations reveal that the formation of interface state with Rashba spin splitting causes the inverse Edelstein effect, whose magnitude is sensitive to the adsorption configuration of the molecules.
Collapse
Affiliation(s)
- H Isshiki
- Institute for Solid State Physics , The University of Tokyo , Kashiwa , Chiba 277-8581 , Japan
| | - K Kondou
- Institute for Solid State Physics , The University of Tokyo , Kashiwa , Chiba 277-8581 , Japan
- RIKEN Center for Emergent Matter Science (CEMS) , Wako , Saitama 351-0198 , Japan
| | - S Takizawa
- Institute for Solid State Physics , The University of Tokyo , Kashiwa , Chiba 277-8581 , Japan
| | - K Shimose
- Graduate School of Engineering Science , Osaka University , Toyonaka , Osaka 560-8531 , Japan
| | - T Kawabe
- Graduate School of Engineering Science , Osaka University , Toyonaka , Osaka 560-8531 , Japan
| | - E Minamitani
- Graduate School of Engineering , The University of Tokyo , Bunkyo , Tokyo 113-8656 , Japan
| | - N Yamaguchi
- Graduate School of Natural Science and Technology , Kanazawa University , Kanazawa , Ishikawa 920-1192 , Japan
| | - F Ishii
- Nanomaterials Research Institute , Kanazawa University , Kanazawa , Ishikawa 920-1192 , Japan
| | - A Shiotari
- Department of Advanced Materials Science , The University of Tokyo , Kashiwa , Chiba 277-8561 , Japan
| | - Y Sugimoto
- Department of Advanced Materials Science , The University of Tokyo , Kashiwa , Chiba 277-8561 , Japan
| | - S Miwa
- Institute for Solid State Physics , The University of Tokyo , Kashiwa , Chiba 277-8581 , Japan
- Graduate School of Engineering Science , Osaka University , Toyonaka , Osaka 560-8531 , Japan
| | - Y Otani
- Institute for Solid State Physics , The University of Tokyo , Kashiwa , Chiba 277-8581 , Japan
- RIKEN Center for Emergent Matter Science (CEMS) , Wako , Saitama 351-0198 , Japan
| |
Collapse
|
31
|
Sakurai K, Dainichi T, Garcet S, Tsuchiya S, Yamamoto Y, Kitoh A, Honda T, Nomura T, Egawa G, Otsuka A, Nakajima S, Matsumoto R, Nakano Y, Otsuka M, Iwakura Y, Grinberg-Bleyer Y, Ghosh S, Sugimoto Y, Guttman-Yassky E, Krueger JG, Kabashima K. Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis. J Allergy Clin Immunol 2019; 144:1036-1049. [DOI: 10.1016/j.jaci.2019.06.019] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Revised: 06/06/2019] [Accepted: 06/10/2019] [Indexed: 01/07/2023]
|
32
|
Okuyama Y, Ashihara T, Ozawa T, Fujii Y, Kato K, Sugimoto Y, Nakagawa Y. P4764Relationship of the duration of pulmonary vein isolation-refractory non-paroxysmal atrial fibrillation to the middle- to long-term outcome of the ExTRa Mapping-guided ablation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
It is reported that for patients with non-paroxysmal (persistent or long-standing persistent) atrial fibrillation (Non-PAF), extended ablation to atrial walls in addition to pulmonary vein isolation (PVI) did not improve the long-term outcome. On the other hand, modulation of Non-PAF drivers (or perpetuators) has been proposed as one of the alternative effective ablation strategies for Non-PAF.
Purpose
To clarify whether the rotor ablation under online real-time high-density phase mapping system is effective for PVI-refractory Non-PAF ablation.
Methods
Under such circumstances, our academic group had recently developed the online real-time high-density phase mapping system (ExTRa Mapping™) by industrial alliance. The phase map moving images were based on 41 intra-atrial bipolar signals recorded by a 20-pole spiral-shaped catheter (2.5 cm in diameter) and on in silicorapid prediction of spatio-temporal atrial excitations (artificial intelligence system). Then we applied the ExTRa Mapping to clinical practice in order to directly visualize rotors in patients with Non-PAF, and investigated the middle- to long-term outcome of the ExTRa Mapping-guided rotor ablation (ExTRa-ABL).
Results
Thirty-eight patients (63±8 y/o, 30 males) with Non-PAF demonstrating refractoriness to PVI were enrolled in this study. Ablation for cavo-tricuspid isthmus and/or superior vena cava isolation was additionally performed at physicians' discretion. After these procedures, the ExTRa-ABL was performed in order to modify Non-PAF substrates, causing rotor control. The modification of the rotors was evaluated by re-mapping with the use of the ExTRa Mapping at the end of each ablation session. Patients were followed at 1, 3, 6 months and every year after the procedure. All of them were followed for 21±8 months. During the follow-up period, Non-PAF was recurred in only 8 of 38 (21%). Furthermore, we found if PVI-refractory Non-PAF duration was shorter than 6 years, the non-recurrence rate remained ≥80% (see Figure), which was markedly better outcome comparing with previous reports with regard to Non-PAF ablation.
Figure 1
Conclusion
Comparing with conventional Non-PAF ablation strategies, our novel approach with the use of the online real-time high-density phase mapping system might improve medium- to long-term outcome of PVI-refractory Non-PAF treatment.
Collapse
Affiliation(s)
- Y Okuyama
- Shiga University of Medical Science, Department of Cardiovascular Medicine, Otsu, Japan
| | - T Ashihara
- Shiga University of Medical Science, Department of Cardiovascular Medicine, Department of Medical Informatics and Biomedical Engineering, Otsu, Japan
| | - T Ozawa
- Shiga University of Medical Science, Department of Cardiovascular Medicine, Otsu, Japan
| | - Y Fujii
- Shiga University of Medical Science, Department of Cardiovascular Medicine, Otsu, Japan
| | - K Kato
- Shiga University of Medical Science, Department of Cardiovascular Medicine, Otsu, Japan
| | - Y Sugimoto
- Shiga University of Medical Science, Department of Medical Informatics and Biomedical Engineering, Otsu, Japan
| | - Y Nakagawa
- Shiga University of Medical Science, Department of Cardiovascular Medicine, Department of Medical Informatics and Biomedical Engineering, Otsu, Japan
| |
Collapse
|
33
|
Iwasaki R, Tsuge K, Kishimoto K, Hayashi Y, Iwaana T, Hohjoh H, Inazumi T, Kawahara A, Tsuchiya S, Sugimoto Y. Essential role of prostaglandin E 2 and the EP3 receptor in lymphatic vessel development during zebrafish embryogenesis. Sci Rep 2019; 9:7650. [PMID: 31114004 PMCID: PMC6529442 DOI: 10.1038/s41598-019-44095-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2017] [Accepted: 05/09/2019] [Indexed: 12/15/2022] Open
Abstract
Lymphatic endothelial cells arise from the venous endothelial cells in embryonic lymphatic development. However, the molecular mechanisms remain to be elucidated. We here report that prostaglandin (PG) E2 plays essential roles in the embryonic lymphatic development through the EP3 receptor, one of the PGE2 receptors. Knockdown of the EP3 receptor or inhibition of cyclooxygenases (COX; rate-limiting enzymes for PG synthesis) impaired lymphatic development by perturbing lymphatic specification during zebrafish development. These impairments by COX inhibition were recovered by treatment with sulprostone (EP1/3 agonist). Knockdown of the EP3 receptor further demonstrated its requirement in the expression of sex determining region Y-box 18 (sox18) and nuclear receptor subfamily 2, group F, member 2 (nr2f2), essential factors of the lymphatic specification. The EP3 receptor was expressed in the posterior cardinal vein (region of embryonic lymphatic development) and the adjacent intermediate cell mass (ICM) during the lymphatic specification. COX1 was expressed in the region more upstream of the posterior cardinal vein relative to the EP3 receptor, and the COX1-selective inhibitor impaired the lymphatic specification. On the other hand, two COX2 subtypes did not show distinct sites of expression around the region of expression of the EP3 receptor. Finally, we generated EP3-deficient zebrafish, which also showed defect in lymphatic specification and development. Thus, we demonstrated that COX1-derived PGE2-EP3 pathway is required for embryonic lymphatic development by upregulating the expression of key factors for the lymphatic specification.
Collapse
Affiliation(s)
- Ryo Iwasaki
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan
| | - Kyoshiro Tsuge
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan
| | - Koichiro Kishimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan
| | - Yuta Hayashi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan
| | - Takuya Iwaana
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan
| | - Hirofumi Hohjoh
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan.,Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST), 1-7-1 Otemachi, Chiyoda-ku, 100-0004, Tokyo, Japan
| | - Atsuo Kawahara
- Laboratory for Developmental Biology, Center for Medical Education and Sciences, Graduate School of Medical Science, University of Yamanashi, 1110 Shimokato, Chuo, 409-3898, Yamanashi, Japan
| | - Soken Tsuchiya
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan. .,Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST), 1-7-1 Otemachi, Chiyoda-ku, 100-0004, Tokyo, Japan.
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan. .,Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST), 1-7-1 Otemachi, Chiyoda-ku, 100-0004, Tokyo, Japan.
| |
Collapse
|
34
|
Kitadate Y, Jörg DJ, Tokue M, Maruyama A, Ichikawa R, Tsuchiya S, Segi-Nishida E, Nakagawa T, Uchida A, Kimura-Yoshida C, Mizuno S, Sugiyama F, Azami T, Ema M, Noda C, Kobayashi S, Matsuo I, Kanai Y, Nagasawa T, Sugimoto Y, Takahashi S, Simons BD, Yoshida S. Competition for Mitogens Regulates Spermatogenic Stem Cell Homeostasis in an Open Niche. Cell Stem Cell 2018; 24:79-92.e6. [PMID: 30581080 PMCID: PMC6327111 DOI: 10.1016/j.stem.2018.11.013] [Citation(s) in RCA: 88] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Revised: 08/30/2018] [Accepted: 11/09/2018] [Indexed: 01/08/2023]
Abstract
In many tissues, homeostasis is maintained by physical contact between stem cells and an anatomically defined niche. However, how stem cell homeostasis is achieved in environments where cells are motile and dispersed among their progeny remains unknown. Using murine spermatogenesis as a model, we find that spermatogenic stem cell density is tightly regulated by the supply of fibroblast growth factors (FGFs) from lymphatic endothelial cells. We propose that stem cell homeostasis is achieved through competition for a limited supply of FGFs. We show that the quantitative dependence of stem cell density on FGF dosage, the biased localization of stem cells toward FGF sources, and stem cell dynamics during regeneration following injury can all be predicted and explained within the framework of a minimal theoretical model based on "mitogen competition." We propose that this model provides a generic and robust mechanism to support stem cell homeostasis in open, or facultative, niche environments.
Collapse
Affiliation(s)
- Yu Kitadate
- Division of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan; Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (Sokendai), 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan
| | - David J Jörg
- The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK; Cavendish Laboratory, Department of Physics, University of Cambridge, J.J. Thomson Avenue, Cambridge CB3 0HE, UK
| | - Moe Tokue
- Division of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan; Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (Sokendai), 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan
| | - Ayumi Maruyama
- Division of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan
| | - Rie Ichikawa
- Division of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan
| | - Soken Tsuchiya
- Department of Pharmaceutical Biochemistry, Kumamoto University Graduate School of Pharmaceutical Sciences, Oe-Honmachi, Kumamoto 862-0973, Japan; AMED-CREST, Japan Agency for Medical Research and Development, Tokyo 100-0004, Japan
| | - Eri Segi-Nishida
- Department of Biological Science and Technology, Faculty of Industrial Science and Technology, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan
| | - Toshinori Nakagawa
- Division of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan; Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (Sokendai), 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan
| | - Aya Uchida
- Department of Veterinary Anatomy, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan
| | - Chiharu Kimura-Yoshida
- Department of Molecular Embryology, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization 840, Murodo-cho, Izumi, Osaka, 594-1101, Japan
| | - Seiya Mizuno
- Laboratory Animal Resource Center, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan
| | - Fumihiro Sugiyama
- Laboratory Animal Resource Center, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan
| | - Takuya Azami
- Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science, Seta, Tsukinowa-cho, Otsu, Shiga 520-2192, Japan
| | - Masatsugu Ema
- Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science, Seta, Tsukinowa-cho, Otsu, Shiga 520-2192, Japan
| | - Chiyo Noda
- Division of Environmental Photobiology, National Institute for Basic Biology, Okazaki 444-8585, Japan
| | - Satoru Kobayashi
- Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan
| | - Isao Matsuo
- Department of Molecular Embryology, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization 840, Murodo-cho, Izumi, Osaka, 594-1101, Japan
| | - Yoshiakira Kanai
- Department of Veterinary Anatomy, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan
| | - Takashi Nagasawa
- Laboratory of Stem Cell Biology and Developmental Immunology, Graduate School of Frontier Biosciences, Graduate School of Medicine, Immunology Frontier Research Center, World Premier International Research Center (WPI), Osaka University, Osaka 565-0871, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Kumamoto University Graduate School of Pharmaceutical Sciences, Oe-Honmachi, Kumamoto 862-0973, Japan; AMED-CREST, Japan Agency for Medical Research and Development, Tokyo 100-0004, Japan
| | - Satoru Takahashi
- Laboratory Animal Resource Center, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan; Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan
| | - Benjamin D Simons
- The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK; Cavendish Laboratory, Department of Physics, University of Cambridge, J.J. Thomson Avenue, Cambridge CB3 0HE, UK; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge CB2 1QR, UK.
| | - Shosei Yoshida
- Division of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan; Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (Sokendai), 5-1 Higashiyama, Myodaiji, Okazaki 444-8787, Japan; AMED-CREST, Japan Agency for Medical Research and Development, Tokyo 100-0004, Japan.
| |
Collapse
|
35
|
Matsumoto R, Dainichi T, Tsuchiya S, Nomura T, Kitoh A, Hayden MS, Ishii KJ, Tanaka M, Honda T, Egawa G, Otsuka A, Nakajima S, Sakurai K, Nakano Y, Kobayashi T, Sugimoto Y, Kabashima K. Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation. JCI Insight 2018; 3:121175. [PMID: 30089718 DOI: 10.1172/jci.insight.121175] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Accepted: 06/21/2018] [Indexed: 12/25/2022] Open
Abstract
Epithelial cells are the first line of defense against external dangers, and contribute to induction of adaptive immunity including Th17 responses. However, it is unclear whether specific epithelial signaling pathways are essential for the development of robust IL-17-mediated immune responses. In mice, the development of psoriatic inflammation induced by imiquimod required keratinocyte TRAF6. Conditional deletion of TRAF6 in keratinocytes abrogated dendritic cell activation, IL-23 production, and IL-17 production by γδ T cells at the imiquimod-treated sites. In contrast, hapten-induced contact hypersensitivity and papain-induced IgE production were not affected by loss of TRAF6. Loss of psoriatic inflammation was not solely due to defective imiquimod sensing, as subcutaneous administration of IL-23 restored IL-17 production but did not reconstitute psoriatic pathology in the mutant animals. Thus, TRAF6 was required for the full development of IL-17-mediated inflammation. Therefore, epithelial TRAF6 signaling plays an essential role in both triggering and propagating IL-17-mediated psoriatic inflammation.
Collapse
Affiliation(s)
- Reiko Matsumoto
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Teruki Dainichi
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Soken Tsuchiya
- Department of Pharmaceutical Biochemistry, Kumamoto University Faculty of Life Sciences, Kumamoto, Japan
| | - Takashi Nomura
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Akihiko Kitoh
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Matthew S Hayden
- Section of Dermatology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA
| | - Ken J Ishii
- Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.,Laboratory of Vaccine Science, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan
| | - Mayuri Tanaka
- Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.,Laboratory of Vaccine Science, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan
| | - Tetsuya Honda
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Gyohei Egawa
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Atsushi Otsuka
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Saeko Nakajima
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Kenji Sakurai
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Yuri Nakano
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Takashi Kobayashi
- Department of Infectious Disease Control, Faculty of Medicine, Oita University, Oita, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Kumamoto University Faculty of Life Sciences, Kumamoto, Japan
| | - Kenji Kabashima
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.,Singapore Immunology Network (SIgN) and Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore
| |
Collapse
|
36
|
Kato H, Kai A, Kawabata T, Sunderhaus JD, McAfoos TJ, Finefield JM, Sugimoto Y, Williams RM, Tsukamoto S. Corrigendum to “Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts” [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975–4978]. Bioorg Med Chem Lett 2018; 28:2573. [DOI: 10.1016/j.bmcl.2018.06.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
37
|
Abbott BP, Abbott R, Abbott TD, Abernathy MR, Acernese F, Ackley K, Adams C, Adams T, Addesso P, Adhikari RX, Adya VB, Affeldt C, Agathos M, Agatsuma K, Aggarwal N, Aguiar OD, Aiello L, Ain A, Ajith P, Akutsu T, Allen B, Allocca A, Altin PA, Ananyeva A, Anderson SB, Anderson WG, Ando M, Appert S, Arai K, Araya A, Araya MC, Areeda JS, Arnaud N, Arun KG, Asada H, Ascenzi S, Ashton G, Aso Y, Ast M, Aston SM, Astone P, Atsuta S, Aufmuth P, Aulbert C, Avila-Alvarez A, Awai K, Babak S, Bacon P, Bader MKM, Baiotti L, Baker PT, Baldaccini F, Ballardin G, Ballmer SW, Barayoga JC, Barclay SE, Barish BC, Barker D, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Barton MA, Bartos I, Bassiri R, Basti A, Batch JC, Baune C, Bavigadda V, Bazzan M, Bécsy B, Beer C, Bejger M, Belahcene I, Belgin M, Bell AS, Berger BK, Bergmann G, Berry CPL, Bersanetti D, Bertolini A, Betzwieser J, Bhagwat S, Bhandare R, Bilenko IA, Billingsley G, Billman CR, Birch J, Birney R, Birnholtz O, Biscans S, Bisht A, Bitossi M, Biwer C, Bizouard MA, Blackburn JK, Blackman J, Blair CD, Blair DG, Blair RM, Bloemen S, Bock O, Boer M, Bogaert G, Bohe A, Bondu F, Bonnand R, Boom BA, Bork R, Boschi V, Bose S, Bouffanais Y, Bozzi A, Bradaschia C, Brady PR, Braginsky VB, Branchesi M, Brau JE, Briant T, Brillet A, Brinkmann M, Brisson V, Brockill P, Broida JE, Brooks AF, Brown DA, Brown DD, Brown NM, Brunett S, Buchanan CC, Buikema A, Bulik T, Bulten HJ, Buonanno A, Buskulic D, Buy C, Byer RL, Cabero M, Cadonati L, Cagnoli G, Cahillane C, Calderón Bustillo J, Callister TA, Calloni E, Camp JB, Cannon KC, Cao H, Cao J, Capano CD, Capocasa E, Carbognani F, Caride S, Casanueva Diaz J, Casentini C, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Cella G, Cepeda CB, Cerboni Baiardi L, Cerretani G, Cesarini E, Chamberlin SJ, Chan M, Chao S, Charlton P, Chassande-Mottin E, Cheeseboro BD, Chen HY, Chen Y, Cheng HP, Chincarini A, Chiummo A, Chmiel T, Cho HS, Cho M, Chow JH, Christensen N, Chu Q, Chua AJK, Chua S, Chung S, Ciani G, Clara F, Clark JA, Cleva F, Cocchieri C, Coccia E, Cohadon PF, Colla A, Collette CG, Cominsky L, Constancio M, Conti L, Cooper SJ, Corbitt TR, Cornish N, Corsi A, Cortese S, Costa CA, Coughlin MW, Coughlin SB, Coulon JP, Countryman ST, Couvares P, Covas PB, Cowan EE, Coward DM, Cowart MJ, Coyne DC, Coyne R, Creighton JDE, Creighton TD, Cripe J, Crowder SG, Cullen TJ, Cumming A, Cunningham L, Cuoco E, Canton TD, Danilishin SL, D’Antonio S, Danzmann K, Dasgupta A, Da Silva Costa CF, Dattilo V, Dave I, Davier M, Davies GS, Davis D, Daw EJ, Day B, Day R, De S, DeBra D, Debreczeni G, Degallaix J, De Laurentis M, Deléglise S, Del Pozzo W, Denker T, Dent T, Dergachev V, De Rosa R, DeRosa RT, DeSalvo R, Devine RC, Dhurandhar S, Díaz MC, Fiore LD, Giovanni MD, Girolamo TD, Lieto AD, Pace SD, Palma ID, Virgilio AD, Doctor Z, Doi K, Dolique V, Donovan F, Dooley KL, Doravari S, Dorrington I, Douglas R, Dovale Álvarez M, Downes TP, Drago M, Drever RWP, Driggers JC, Du Z, Ducrot M, Dwyer SE, Eda K, Edo TB, Edwards MC, Effler A, Eggenstein HB, Ehrens P, Eichholz J, Eikenberry SS, Eisenstein RA, Essick RC, Etienne Z, Etzel T, Evans M, Evans TM, Everett R, Factourovich M, Fafone V, Fair H, Fairhurst S, Fan X, Farinon S, Farr B, Farr WM, Fauchon-Jones EJ, Favata M, Fays M, Fehrmann H, Fejer MM, Fernández Galiana A, Ferrante I, Ferreira EC, Ferrini F, Fidecaro F, Fiori I, Fiorucci D, Fisher RP, Flaminio R, Fletcher M, Fong H, Forsyth SS, Fournier JD, Frasca S, Frasconi F, Frei Z, Freise A, Frey R, Frey V, Fries EM, Fritschel P, Frolov VV, Fujii Y, Fujimoto MK, Fulda P, Fyffe M, Gabbard H, Gadre BU, Gaebel SM, Gair JR, Gammaitoni L, Gaonkar SG, Garufi F, Gaur G, Gayathri V, Gehrels N, Gemme G, Genin E, Gennai A, George J, Gergely L, Germain V, Ghonge S, Ghosh A, Ghosh A, Ghosh S, Giaime JA, Giardina KD, Giazotto A, Gill K, Glaefke A, Goetz E, Goetz R, Gondan L, González G, Gonzalez Castro JM, Gopakumar A, Gorodetsky ML, Gossan SE, Gosselin M, Gouaty R, Grado A, Graef C, Granata M, Grant A, Gras S, Gray C, Greco G, Green AC, Groot P, Grote H, Grunewald S, Guidi GM, Guo X, Gupta A, Gupta MK, Gushwa KE, Gustafson EK, Gustafson R, Hacker JJ, Hagiwara A, Hall BR, Hall ED, Hammond G, Haney M, Hanke MM, Hanks J, Hanna C, Hannam MD, Hanson J, Hardwick T, Harms J, Harry GM, Harry IW, Hart MJ, Hartman MT, Haster CJ, Haughian K, Hayama K, Healy J, Heidmann A, Heintze MC, Heitmann H, Hello P, Hemming G, Hendry M, Heng IS, Hennig J, Henry J, Heptonstall AW, Heurs M, Hild S, Hirose E, Hoak D, Hofman D, Holt K, Holz DE, Hopkins P, Hough J, Houston EA, Howell EJ, Hu YM, Huerta EA, Huet D, Hughey B, Husa S, Huttner SH, Huynh-Dinh T, Indik N, Ingram DR, Inta R, Ioka K, Isa HN, Isac JM, Isi M, Isogai T, Itoh Y, Iyer BR, Izumi K, Jacqmin T, Jani K, Jaranowski P, Jawahar S, Jiménez-Forteza F, Johnson WW, Jones DI, Jones R, Jonker RJG, Ju L, Junker J, Kagawa T, Kajita T, Kakizaki M, Kalaghatgi CV, Kalogera V, Kamiizumi M, Kanda N, Kandhasamy S, Kanemura S, Kaneyama M, Kang G, Kanner JB, Karki S, Karvinen KS, Kasprzack M, Kataoka Y, Katsavounidis E, Katzman W, Kaufer S, Kaur T, Kawabe K, Kawai N, Kawamura S, Kéfélian F, Keitel D, Kelley DB, Kennedy R, Key JS, Khalili FY, Khan I, Khan S, Khan Z, Khazanov EA, Kijbunchoo N, Kim C, Kim H, Kim JC, Kim J, Kim W, Kim YM, Kimbrell SJ, Kimura N, King EJ, King PJ, Kirchhoff R, Kissel JS, Klein B, Kleybolte L, Klimenko S, Koch P, Koehlenbeck SM, Kojima Y, Kokeyama K, Koley S, Komori K, Kondrashov V, Kontos A, Korobko M, Korth WZ, Kotake K, Kowalska I, Kozak DB, Krämer C, Kringel V, Krishnan B, Królak A, Kuehn G, Kumar P, Kumar R, Kumar R, Kuo L, Kuroda K, Kutynia A, Kuwahara Y, Lackey BD, Landry M, Lang RN, Lange J, Lantz B, Lanza RK, Lartaux-Vollard A, Lasky PD, Laxen M, Lazzarini A, Lazzaro C, Leaci P, Leavey S, Lebigot EO, Lee CH, Lee HK, Lee HM, Lee HW, Lee K, Lehmann J, Lenon A, Leonardi M, Leong JR, Leroy N, Letendre N, Levin Y, Li TGF, Libson A, Littenberg TB, Liu J, Lockerbie NA, Lombardi AL, London LT, Lord JE, Lorenzini M, Loriette V, Lormand M, Losurdo G, Lough JD, Lousto CO, Lovelace G, Lück H, Lundgren AP, Lynch R, Ma Y, Macfoy S, Machenschalk B, MacInnis M, Macleod DM, Magaña-Sandoval F, Majorana E, Maksimovic I, Malvezzi V, Man N, Mandic V, Mangano V, Mano S, Mansell GL, Manske M, Mantovani M, Marchesoni F, Marchio M, Marion F, Márka S, Márka Z, Markosyan AS, Maros E, Martelli F, Martellini L, Martin IW, Martynov DV, Mason K, Masserot A, Massinger TJ, Masso-Reid M, Mastrogiovanni S, Matichard F, Matone L, Matsumoto N, Matsushima F, Mavalvala N, Mazumder N, McCarthy R, McClelland DE, McCormick S, McGrath C, McGuire SC, McIntyre G, McIver J, McManus DJ, McRae T, McWilliams ST, Meacher D, Meadors GD, Meidam J, Melatos A, Mendell G, Mendoza-Gandara D, Mercer RA, Merilh EL, Merzougui M, Meshkov S, Messenger C, Messick C, Metzdorff R, Meyers PM, Mezzani F, Miao H, Michel C, Michimura Y, Middleton H, Mikhailov EE, Milano L, Miller AL, Miller A, Miller BB, Miller J, Millhouse M, Minenkov Y, Ming J, Mirshekari S, Mishra C, Mitrofanov VP, Mitselmakher G, Mittleman R, Miyakawa O, Miyamoto A, Miyamoto T, Miyoki S, Moggi A, Mohan M, Mohapatra SRP, Montani M, Moore BC, Moore CJ, Moraru D, Moreno G, Morii W, Morisaki S, Moriwaki Y, Morriss SR, Mours B, Mow-Lowry CM, Mueller G, Muir AW, Mukherjee A, Mukherjee D, Mukherjee S, Mukund N, Mullavey A, Munch J, Muniz EAM, Murray PG, Mytidis A, Nagano S, Nakamura K, Nakamura T, Nakano H, Nakano M, Nakano M, Nakao K, Napier K, Nardecchia I, Narikawa T, Naticchioni L, Nelemans G, Nelson TJN, Neri M, Nery M, Neunzert A, Newport JM, Newton G, Nguyen TT, Ni WT, Nielsen AB, Nissanke S, Nitz A, Noack A, Nocera F, Nolting D, Normandin MEN, Nuttall LK, Oberling J, Ochsner E, Oelker E, Ogin GH, Oh JJ, Oh SH, Ohashi M, Ohishi N, Ohkawa M, Ohme F, Okutomi K, Oliver M, Ono K, Ono Y, Oohara K, Oppermann P, Oram RJ, O’Reilly B, O’Shaughnessy R, Ottaway DJ, Overmier H, Owen BJ, Pace AE, Page J, Pai A, Pai SA, Palamos JR, Palashov O, Palomba C, Pal-Singh A, Pan H, Pankow C, Pannarale F, Pant BC, Paoletti F, Paoli A, Papa MA, Paris HR, Parker W, Pascucci D, Pasqualetti A, Passaquieti R, Passuello D, Patricelli B, Pearlstone BL, Pedraza M, Pedurand R, Pekowsky L, Pele A, Peña Arellano FE, Penn S, Perez CJ, Perreca A, Perri LM, Pfeiffer HP, Phelps M, Piccinni OJ, Pichot M, Piergiovanni F, Pierro V, Pillant G, Pinard L, Pinto IM, Pitkin M, Poe M, Poggiani R, Popolizio P, Post A, Powell J, Prasad J, Pratt JWW, Predoi V, Prestegard T, Prijatelj M, Principe M, Privitera S, Prodi GA, Prokhorov LG, Puncken O, Punturo M, Puppo P, Pürrer M, Qi H, Qin J, Qiu S, Quetschke V, Quintero EA, Quitzow-James R, Raab FJ, Rabeling DS, Radkins H, Raffai P, Raja S, Rajan C, Rakhmanov M, Rapagnani P, Raymond V, Razzano M, Re V, Read J, Regimbau T, Rei L, Reid S, Reitze DH, Rew H, Reyes SD, Rhoades E, Ricci F, Riles K, Rizzo M, Robertson NA, Robie R, Robinet F, Rocchi A, Rolland L, Rollins JG, Roma VJ, Romano R, Romie JH, Rosińska D, Rowan S, Rüdiger A, Ruggi P, Ryan K, Sachdev S, Sadecki T, Sadeghian L, Sago N, Saijo M, Saito Y, Sakai K, Sakellariadou M, Salconi L, Saleem M, Salemi F, Samajdar A, Sammut L, Sampson LM, Sanchez EJ, Sandberg V, Sanders JR, Sasaki Y, Sassolas B, Sathyaprakash BS, Sato S, Sato T, Saulson PR, Sauter O, Savage RL, Sawadsky A, Schale P, Scheuer J, Schmidt E, Schmidt J, Schmidt P, Schnabel R, Schofield RMS, Schönbeck A, Schreiber E, Schuette D, Schutz BF, Schwalbe SG, Scott J, Scott SM, Sekiguchi T, Sekiguchi Y, Sellers D, Sengupta AS, Sentenac D, Sequino V, Sergeev A, Setyawati Y, Shaddock DA, Shaffer TJ, Shahriar MS, Shapiro B, Shawhan P, Sheperd A, Shibata M, Shikano Y, Shimoda T, Shoda A, Shoemaker DH, Shoemaker DM, Siellez K, Siemens X, Sieniawska M, Sigg D, Silva AD, Singer A, Singer LP, Singh A, Singh R, Singhal A, Sintes AM, Slagmolen BJJ, Smith B, Smith JR, Smith RJE, Somiya K, Son EJ, Sorazu B, Sorrentino F, Souradeep T, Spencer AP, Srivastava AK, Staley A, Steinke M, Steinlechner J, Steinlechner S, Steinmeyer D, Stephens BC, Stevenson SP, Stone R, Strain KA, Straniero N, Stratta G, Strigin SE, Sturani R, Stuver AL, Sugimoto Y, Summerscales TZ, Sun L, Sunil S, Sutton PJ, Suzuki T, Swinkels BL, Szczepańczyk MJ, Tacca M, Tagoshi H, Takada S, Takahashi H, Takahashi R, Takamori A, Talukder D, Tanaka H, Tanaka K, Tanaka T, Tanner DB, Tápai M, Taracchini A, Tatsumi D, Taylor R, Telada S, Theeg T, Thomas EG, Thomas M, Thomas P, Thorne KA, Thrane E, Tippens T, Tiwari S, Tiwari V, Tokmakov KV, Toland K, Tomaru T, Tomlinson C, Tonelli M, Tornasi Z, Torrie CI, Töyrä D, Travasso F, Traylor G, Trifirò D, Trinastic J, Tringali MC, Trozzo L, Tse M, Tso R, Tsubono K, Tsuzuki T, Turconi M, Tuyenbayev D, Uchiyama T, Uehara T, Ueki S, Ueno K, Ugolini D, Unnikrishnan CS, Urban AL, Ushiba T, Usman SA, Vahlbruch H, Vajente G, Valdes G, van Bakel N, van Beuzekom M, van den Brand JFJ, Van Den Broeck C, Vander-Hyde DC, van der Schaaf L, van Heijningen JV, van Putten MHPM, van Veggel AA, Vardaro M, Varma V, Vass S, Vasúth M, Vecchio A, Vedovato G, Veitch J, Veitch PJ, Venkateswara K, Venugopalan G, Verkindt D, Vetrano F, Viceré A, Viets AD, Vinciguerra S, Vine DJ, Vinet JY, Vitale S, Vo T, Vocca H, Vorvick C, Voss DV, Vousden WD, Vyatchanin SP, Wade AR, Wade LE, Wade M, Wakamatsu T, Walker M, Wallace L, Walsh S, Wang G, Wang H, Wang M, Wang Y, Ward RL, Warner J, Was M, Watchi J, Weaver B, Wei LW, Weinert M, Weinstein AJ, Weiss R, Wen L, Weßels P, Westphal T, Wette K, Whelan JT, Whiting BF, Whittle C, Williams D, Williams RD, Williamson AR, Willis JL, Willke B, Wimmer MH, Winkler W, Wipf CC, Wittel H, Woan G, Woehler J, Worden J, Wright JL, Wu DS, Wu G, Yam W, Yamamoto H, Yamamoto K, Yamamoto T, Yancey CC, Yano K, Yap MJ, Yokoyama J, Yokozawa T, Yoon TH, Yu H, Yu H, Yuzurihara H, Yvert M, Zadrożny A, Zangrando L, Zanolin M, Zeidler S, Zendri JP, Zevin M, Zhang L, Zhang M, Zhang T, Zhang Y, Zhao C, Zhou M, Zhou Z, Zhu SJ, Zhu XJ, Zucker ME, Zweizig J. Prospects for observing and localizing gravitational-wave transients with Advanced LIGO, Advanced Virgo and KAGRA. Living Rev Relativ 2018; 21:3. [PMID: 29725242 PMCID: PMC5920066 DOI: 10.1007/s41114-018-0012-9] [Citation(s) in RCA: 67] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2017] [Accepted: 02/07/2018] [Indexed: 05/21/2023]
Abstract
We present possible observing scenarios for the Advanced LIGO, Advanced Virgo and KAGRA gravitational-wave detectors over the next decade, with the intention of providing information to the astronomy community to facilitate planning for multi-messenger astronomy with gravitational waves. We estimate the sensitivity of the network to transient gravitational-wave signals, and study the capability of the network to determine the sky location of the source. We report our findings for gravitational-wave transients, with particular focus on gravitational-wave signals from the inspiral of binary neutron star systems, which are the most promising targets for multi-messenger astronomy. The ability to localize the sources of the detected signals depends on the geographical distribution of the detectors and their relative sensitivity, and [Formula: see text] credible regions can be as large as thousands of square degrees when only two sensitive detectors are operational. Determining the sky position of a significant fraction of detected signals to areas of 5-[Formula: see text] requires at least three detectors of sensitivity within a factor of [Formula: see text] of each other and with a broad frequency bandwidth. When all detectors, including KAGRA and the third LIGO detector in India, reach design sensitivity, a significant fraction of gravitational-wave signals will be localized to a few square degrees by gravitational-wave observations alone.
Collapse
Affiliation(s)
- B. P. Abbott
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - R. Abbott
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - T. D. Abbott
- Louisiana State University, Baton Rouge, LA 70803 USA
| | | | - F. Acernese
- Università di Salerno, Fisciano, I-84084 Salerno Italy
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - K. Ackley
- University of Florida, Gainesville, FL 32611 USA
| | - C. Adams
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - T. Adams
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - P. Addesso
- University of Sannio at Benevento, I-82100 Benevento, Italy
- INFN, Sezione di Napoli, I-80100 Napoli, Italy
| | - R. X. Adhikari
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - V. B. Adya
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - C. Affeldt
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - M. Agathos
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | - K. Agatsuma
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | - N. Aggarwal
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - O. D. Aguiar
- Instituto Nacional de Pesquisas Espaciais, 12227-010 São José dos Campos, São Paulo Brazil
| | - L. Aiello
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - A. Ain
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - P. Ajith
- International Centre for Theoretical Sciences, Tata Institute of Fundamental Research, Bengaluru, 560089 India
| | - T. Akutsu
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - B. Allen
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - A. Allocca
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - P. A. Altin
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - A. Ananyeva
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - S. B. Anderson
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - W. G. Anderson
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - M. Ando
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
- The University of Tokyo, Department of Physics, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
- The University of Tokyo, Research Center for the Early Universe, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - S. Appert
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - K. Arai
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - A. Araya
- The University of Tokyo, Earthquake Research Institute, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-0032 Japan
| | - M. C. Araya
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - J. S. Areeda
- California State University Fullerton, Fullerton, CA 92831 USA
| | - N. Arnaud
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - K. G. Arun
- Chennai Mathematical Institute, Chennai, 603103 India
| | - H. Asada
- Hirosaki University, Department of Advanced Physics, 3, Bunkyo-cho, Hirosaki-shi, Aomori 036-8561 Japan
| | - S. Ascenzi
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - G. Ashton
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - Y. Aso
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - M. Ast
- Universität Hamburg, D-22761 Hamburg, Germany
| | - S. M. Aston
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - P. Astone
- INFN, Sezione di Roma, I-00185 Roma, Italy
| | - S. Atsuta
- Tokyo Institute of Technology, Graduate School of Science and Technology, 2-12-1, Ookayama, Meguro-ku, Tokyo 152-8551 Japan
| | - P. Aufmuth
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - C. Aulbert
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | | | - K. Awai
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - S. Babak
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - P. Bacon
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - M. K. M. Bader
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | - L. Baiotti
- Osaka University, Graduate School of Science, Physics, 1-1, Machikaneyama-cho, Toyonaka-shi, Osaka 560-0043 Japan
| | - P. T. Baker
- West Virginia University, Morgantown, WV 26506 USA
- Center for Gravitational Waves and Cosmology, West Virginia University, Morgantown, WV 26505 USA
| | - F. Baldaccini
- Università di Perugia, I-06123 Perugia, Italy
- INFN, Sezione di Perugia, I-06123 Perugia, Italy
| | - G. Ballardin
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | | | - J. C. Barayoga
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - S. E. Barclay
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - B. C. Barish
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - D. Barker
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - F. Barone
- Università di Salerno, Fisciano, I-84084 Salerno Italy
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - B. Barr
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - L. Barsotti
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - M. Barsuglia
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - D. Barta
- Wigner RCP, RMKI, Konkoly Thege Miklós út 29-33, H-1121 Budapest, Hungary
| | - J. Bartlett
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - M. A. Barton
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - I. Bartos
- Columbia University, New York, NY 10027 USA
| | - R. Bassiri
- Stanford University, Stanford, CA 94305 USA
| | - A. Basti
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - J. C. Batch
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - C. Baune
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - V. Bavigadda
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - M. Bazzan
- Università di Padova, Dipartimento di Fisica e Astronomia, I-35131 Padova, Italy
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - B. Bécsy
- MTA Eötvös University, “Lendulet” Astrophysics Research Group, Budapest, 1117 Hungary
| | - C. Beer
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - M. Bejger
- Nicolaus Copernicus Astronomical Center, Polish Academy of Sciences, 00-716 Warsaw, Poland
| | - I. Belahcene
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - M. Belgin
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - A. S. Bell
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - B. K. Berger
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - G. Bergmann
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - C. P. L. Berry
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - D. Bersanetti
- Università degli Studi di Genova, I-16146 Genova, Italy
- INFN, Sezione di Genova, I-16146 Genova, Italy
| | - A. Bertolini
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | - J. Betzwieser
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - S. Bhagwat
- Syracuse University, Syracuse, NY 13244 USA
| | | | - I. A. Bilenko
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | - G. Billingsley
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - J. Birch
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - R. Birney
- SUPA, University of the West of Scotland, Paisley, PA1 2BE United Kingdom
| | - O. Birnholtz
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - S. Biscans
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - A. Bisht
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - M. Bitossi
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - C. Biwer
- Syracuse University, Syracuse, NY 13244 USA
| | - M. A. Bizouard
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - J. K. Blackburn
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - C. D. Blair
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - D. G. Blair
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - R. M. Blair
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - S. Bloemen
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - O. Bock
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - M. Boer
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - G. Bogaert
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - A. Bohe
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - F. Bondu
- Institut de Physique de Rennes, CNRS, Université de Rennes 1, F-35042 Rennes, France
| | - R. Bonnand
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - B. A. Boom
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | - R. Bork
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - V. Boschi
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - S. Bose
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
- Washington State University, Pullman, WA 99164 USA
| | - Y. Bouffanais
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - A. Bozzi
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | | | - P. R. Brady
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - V. B. Braginsky
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | - M. Branchesi
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - J. E. Brau
- University of Oregon, Eugene, OR 97403 USA
| | - T. Briant
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - A. Brillet
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - M. Brinkmann
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - V. Brisson
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - P. Brockill
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | | | - A. F. Brooks
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - D. D. Brown
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - N. M. Brown
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - S. Brunett
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - A. Buikema
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - T. Bulik
- Astronomical Observatory Warsaw University, 00-478 Warsaw, Poland
| | - H. J. Bulten
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- VU University Amsterdam, 1081 HV Amsterdam, The Netherlands
| | - A. Buonanno
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
- University of Maryland, College Park, MD 20742 USA
| | - D. Buskulic
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - C. Buy
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - R. L. Byer
- Stanford University, Stanford, CA 94305 USA
| | - M. Cabero
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - L. Cadonati
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - G. Cagnoli
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
- Université Claude Bernard Lyon 1, F-69622 Villeurbanne, France
| | - C. Cahillane
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - J. Calderón Bustillo
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - T. A. Callister
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - E. Calloni
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
- Università di Napoli ’Federico II’, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - J. B. Camp
- NASA/Goddard Space Flight Center, Greenbelt, MD 20771 USA
| | - K. C. Cannon
- The University of Tokyo, Research Center for the Early Universe, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - H. Cao
- University of Adelaide, Adelaide, South Australia 5005 Australia
| | - J. Cao
- Tsinghua University, Beijing, 100084 China
| | - C. D. Capano
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - E. Capocasa
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - F. Carbognani
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - S. Caride
- Texas Tech University, Lubbock, TX 79409 USA
| | - J. Casanueva Diaz
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - C. Casentini
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - S. Caudill
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - M. Cavaglià
- The University of Mississippi, University, MS 38677 USA
| | - F. Cavalier
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - R. Cavalieri
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - G. Cella
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - C. B. Cepeda
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - L. Cerboni Baiardi
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - G. Cerretani
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - E. Cesarini
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - S. J. Chamberlin
- The Pennsylvania State University, University Park, PA 16802 USA
| | - M. Chan
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - S. Chao
- National Tsing Hua University, Hsinchu City, 30013 Taiwan Republic of China
| | - P. Charlton
- Charles Sturt University, Wagga Wagga, New South Wales 2678 Australia
| | - E. Chassande-Mottin
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - B. D. Cheeseboro
- West Virginia University, Morgantown, WV 26506 USA
- Center for Gravitational Waves and Cosmology, West Virginia University, Morgantown, WV 26505 USA
| | - H. Y. Chen
- University of Chicago, Chicago, IL 60637 USA
| | - Y. Chen
- Caltech CaRT, Pasadena, CA 91125 USA
| | - H.-P. Cheng
- University of Florida, Gainesville, FL 32611 USA
| | | | - A. Chiummo
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - T. Chmiel
- Kenyon College, Gambier, OH 43022 USA
| | - H. S. Cho
- Korea Institute of Science and Technology Information, Daejeon, 34141 Korea
| | - M. Cho
- University of Maryland, College Park, MD 20742 USA
| | - J. H. Chow
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | | | - Q. Chu
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - A. J. K. Chua
- University of Cambridge, Cambridge, CB2 1TN United Kingdom
| | - S. Chua
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - S. Chung
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - G. Ciani
- University of Florida, Gainesville, FL 32611 USA
| | - F. Clara
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - J. A. Clark
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - F. Cleva
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - C. Cocchieri
- The University of Mississippi, University, MS 38677 USA
| | - E. Coccia
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - P.-F. Cohadon
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - A. Colla
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | | | - L. Cominsky
- Sonoma State University, Rohnert Park, CA 94928 USA
| | - M. Constancio
- Instituto Nacional de Pesquisas Espaciais, 12227-010 São José dos Campos, São Paulo Brazil
| | - L. Conti
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - S. J. Cooper
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - T. R. Corbitt
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - N. Cornish
- Montana State University, Bozeman, MT 59717 USA
| | - A. Corsi
- Texas Tech University, Lubbock, TX 79409 USA
| | - S. Cortese
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - C. A. Costa
- Instituto Nacional de Pesquisas Espaciais, 12227-010 São José dos Campos, São Paulo Brazil
| | | | - S. B. Coughlin
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - J.-P. Coulon
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | | | - P. Couvares
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - P. B. Covas
- Universitat de les Illes Balears, IAC3—IEEC, E-07122 Palma de Mallorca, Spain
| | - E. E. Cowan
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - D. M. Coward
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - M. J. Cowart
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - D. C. Coyne
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - R. Coyne
- Texas Tech University, Lubbock, TX 79409 USA
| | | | - T. D. Creighton
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - J. Cripe
- Louisiana State University, Baton Rouge, LA 70803 USA
| | | | - T. J. Cullen
- California State University Fullerton, Fullerton, CA 92831 USA
| | - A. Cumming
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - L. Cunningham
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - E. Cuoco
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - T. Dal Canton
- NASA/Goddard Space Flight Center, Greenbelt, MD 20771 USA
| | | | - S. D’Antonio
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - K. Danzmann
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - A. Dasgupta
- Institute for Plasma Research, Bhat, Gandhinagar 382428 India
| | | | - V. Dattilo
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - I. Dave
- RRCAT, Indore, MP 452013 India
| | - M. Davier
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - G. S. Davies
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - D. Davis
- Syracuse University, Syracuse, NY 13244 USA
| | - E. J. Daw
- The University of Sheffield, Sheffield, S10 2TN United Kingdom
| | - B. Day
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - R. Day
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - S. De
- Syracuse University, Syracuse, NY 13244 USA
| | - D. DeBra
- Stanford University, Stanford, CA 94305 USA
| | - G. Debreczeni
- Wigner RCP, RMKI, Konkoly Thege Miklós út 29-33, H-1121 Budapest, Hungary
| | - J. Degallaix
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - M. De Laurentis
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
- Università di Napoli ’Federico II’, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - S. Deléglise
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - W. Del Pozzo
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - T. Denker
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - T. Dent
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - V. Dergachev
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - R. De Rosa
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
- Università di Napoli ’Federico II’, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - R. T. DeRosa
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - R. DeSalvo
- University of Sannio at Benevento, I-82100 Benevento, Italy
- INFN, Sezione di Napoli, I-80100 Napoli, Italy
- California State University, Los Angeles, 5154 State University Dr, Los Angeles, CA 90032 USA
| | - R. C. Devine
- West Virginia University, Morgantown, WV 26506 USA
- Center for Gravitational Waves and Cosmology, West Virginia University, Morgantown, WV 26505 USA
| | - S. Dhurandhar
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - M. C. Díaz
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - L. Di Fiore
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - M. Di Giovanni
- Università di Trento, Dipartimento di Fisica, I-38123 Povo, Trento Italy
- INFN, Trento Institute for Fundamental Physics and Applications, I-38123 Povo, Trento Italy
| | - T. Di Girolamo
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
- Università di Napoli ’Federico II’, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - A. Di Lieto
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - S. Di Pace
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - I. Di Palma
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | | | - Z. Doctor
- University of Chicago, Chicago, IL 60637 USA
| | - K. Doi
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | - V. Dolique
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - F. Donovan
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - K. L. Dooley
- The University of Mississippi, University, MS 38677 USA
| | - S. Doravari
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - I. Dorrington
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - R. Douglas
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | | | - T. P. Downes
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - M. Drago
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - R. W. P. Drever
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - Z. Du
- Tsinghua University, Beijing, 100084 China
| | - M. Ducrot
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - S. E. Dwyer
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - K. Eda
- The University of Tokyo, Research Center for the Early Universe, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - T. B. Edo
- The University of Sheffield, Sheffield, S10 2TN United Kingdom
| | | | - A. Effler
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - H.-B. Eggenstein
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - P. Ehrens
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - J. Eichholz
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - R. A. Eisenstein
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - R. C. Essick
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - Z. Etienne
- West Virginia University, Morgantown, WV 26506 USA
- Center for Gravitational Waves and Cosmology, West Virginia University, Morgantown, WV 26505 USA
| | - T. Etzel
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - M. Evans
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - T. M. Evans
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - R. Everett
- The Pennsylvania State University, University Park, PA 16802 USA
| | | | - V. Fafone
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - H. Fair
- Syracuse University, Syracuse, NY 13244 USA
| | - S. Fairhurst
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - X. Fan
- Tsinghua University, Beijing, 100084 China
| | - S. Farinon
- INFN, Sezione di Genova, I-16146 Genova, Italy
| | - B. Farr
- University of Chicago, Chicago, IL 60637 USA
| | - W. M. Farr
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | | | - M. Favata
- Montclair State University, Montclair, NJ 07043 USA
| | - M. Fays
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - H. Fehrmann
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | | | | | - I. Ferrante
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - E. C. Ferreira
- Instituto Nacional de Pesquisas Espaciais, 12227-010 São José dos Campos, São Paulo Brazil
| | - F. Ferrini
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - F. Fidecaro
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - I. Fiori
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - D. Fiorucci
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | | | - R. Flaminio
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - M. Fletcher
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - H. Fong
- Canadian Institute for Theoretical Astrophysics, University of Toronto, Toronto, Ontario M5S 3H8 Canada
| | - S. S. Forsyth
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - J.-D. Fournier
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - S. Frasca
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | | | - Z. Frei
- MTA Eötvös University, “Lendulet” Astrophysics Research Group, Budapest, 1117 Hungary
| | - A. Freise
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - R. Frey
- University of Oregon, Eugene, OR 97403 USA
| | - V. Frey
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - E. M. Fries
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - P. Fritschel
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - V. V. Frolov
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - Y. Fujii
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - M.-K. Fujimoto
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - P. Fulda
- University of Florida, Gainesville, FL 32611 USA
- NASA/Goddard Space Flight Center, Greenbelt, MD 20771 USA
| | - M. Fyffe
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - H. Gabbard
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - B. U. Gadre
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - S. M. Gaebel
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - J. R. Gair
- School of Mathematics, University of Edinburgh, Edinburgh, EH9 3FD United Kingdom
| | | | - S. G. Gaonkar
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - F. Garufi
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
- Università di Napoli ’Federico II’, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - G. Gaur
- University and Institute of Advanced Research, Gandhinagar, Gujarat 382007 India
| | - V. Gayathri
- IISER-TVM, CET Campus, Trivandrum Kerala, 695016 India
| | - N. Gehrels
- NASA/Goddard Space Flight Center, Greenbelt, MD 20771 USA
| | - G. Gemme
- INFN, Sezione di Genova, I-16146 Genova, Italy
| | - E. Genin
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - A. Gennai
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | | | - L. Gergely
- University of Szeged, Dóm tér 9, Szeged, 6720 Hungary
| | - V. Germain
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - S. Ghonge
- International Centre for Theoretical Sciences, Tata Institute of Fundamental Research, Bengaluru, 560089 India
| | - Abhirup Ghosh
- International Centre for Theoretical Sciences, Tata Institute of Fundamental Research, Bengaluru, 560089 India
| | - Archisman Ghosh
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- International Centre for Theoretical Sciences, Tata Institute of Fundamental Research, Bengaluru, 560089 India
| | - S. Ghosh
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - J. A. Giaime
- Louisiana State University, Baton Rouge, LA 70803 USA
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | | | | | - K. Gill
- Embry-Riddle Aeronautical University, Prescott, AZ 86301 USA
| | - A. Glaefke
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - E. Goetz
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - R. Goetz
- University of Florida, Gainesville, FL 32611 USA
| | - L. Gondan
- MTA Eötvös University, “Lendulet” Astrophysics Research Group, Budapest, 1117 Hungary
| | - G. González
- Louisiana State University, Baton Rouge, LA 70803 USA
| | | | - A. Gopakumar
- Tata Institute of Fundamental Research, Mumbai, 400005 India
| | - M. L. Gorodetsky
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | - S. E. Gossan
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - M. Gosselin
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - R. Gouaty
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - A. Grado
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
- INAF, Osservatorio Astronomico di Capodimonte, I-80131 Napoli, Italy
| | - C. Graef
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - M. Granata
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - A. Grant
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - S. Gras
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - C. Gray
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - G. Greco
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - A. C. Green
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - P. Groot
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - H. Grote
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - S. Grunewald
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - G. M. Guidi
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - X. Guo
- Tsinghua University, Beijing, 100084 China
| | - A. Gupta
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - M. K. Gupta
- Institute for Plasma Research, Bhat, Gandhinagar 382428 India
| | - K. E. Gushwa
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - E. K. Gustafson
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - J. J. Hacker
- California State University Fullerton, Fullerton, CA 92831 USA
| | - A. Hagiwara
- High Energy Accelerator Research Organization, 1-1, Oho, Tsukuba-shi, Ibaraki 305-0801 Japan
| | - B. R. Hall
- Washington State University, Pullman, WA 99164 USA
| | - E. D. Hall
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - G. Hammond
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - M. Haney
- Tata Institute of Fundamental Research, Mumbai, 400005 India
| | - M. M. Hanke
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - J. Hanks
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - C. Hanna
- The Pennsylvania State University, University Park, PA 16802 USA
| | - M. D. Hannam
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - J. Hanson
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - T. Hardwick
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - J. Harms
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - G. M. Harry
- American University, Washington, DC 20016 USA
| | - I. W. Harry
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - M. J. Hart
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | | | - C.-J. Haster
- University of Birmingham, Birmingham, B15 2TT United Kingdom
- Canadian Institute for Theoretical Astrophysics, University of Toronto, Toronto, Ontario M5S 3H8 Canada
| | - K. Haughian
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - K. Hayama
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - J. Healy
- Rochester Institute of Technology, Rochester, NY 14623 USA
| | - A. Heidmann
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - M. C. Heintze
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - H. Heitmann
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - P. Hello
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - G. Hemming
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - M. Hendry
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - I. S. Heng
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - J. Hennig
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - J. Henry
- Rochester Institute of Technology, Rochester, NY 14623 USA
| | | | - M. Heurs
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - S. Hild
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - E. Hirose
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - D. Hoak
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - D. Hofman
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - K. Holt
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - D. E. Holz
- University of Chicago, Chicago, IL 60637 USA
| | - P. Hopkins
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - J. Hough
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - E. A. Houston
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - E. J. Howell
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - Y. M. Hu
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - E. A. Huerta
- NCSA, University of Illinois at Urbana-Champaign, Urbana, IL 61801 USA
| | - D. Huet
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - B. Hughey
- Embry-Riddle Aeronautical University, Prescott, AZ 86301 USA
| | - S. Husa
- Universitat de les Illes Balears, IAC3—IEEC, E-07122 Palma de Mallorca, Spain
| | - S. H. Huttner
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - T. Huynh-Dinh
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - N. Indik
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - D. R. Ingram
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - R. Inta
- Texas Tech University, Lubbock, TX 79409 USA
| | - K. Ioka
- Center for Gravitational Physics, Yukawa Institute for Theoretical Physics, Kyoto University, Kyoto, 606-8502 Japan
| | - H. N. Isa
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - J.-M. Isac
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - M. Isi
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - T. Isogai
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - Y. Itoh
- The University of Tokyo, Research Center for the Early Universe, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - B. R. Iyer
- International Centre for Theoretical Sciences, Tata Institute of Fundamental Research, Bengaluru, 560089 India
| | - K. Izumi
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - T. Jacqmin
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - K. Jani
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | | | - S. Jawahar
- SUPA, University of Strathclyde, Glasgow, G1 1XQ United Kingdom
| | - F. Jiménez-Forteza
- Universitat de les Illes Balears, IAC3—IEEC, E-07122 Palma de Mallorca, Spain
| | - W. W. Johnson
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - D. I. Jones
- University of Southampton, Southampton, SO17 1BJ United Kingdom
| | - R. Jones
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | | | - L. Ju
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - J. Junker
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - T. Kagawa
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | - T. Kajita
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - M. Kakizaki
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | | | - V. Kalogera
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - M. Kamiizumi
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - N. Kanda
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - S. Kandhasamy
- The University of Mississippi, University, MS 38677 USA
| | - S. Kanemura
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | - M. Kaneyama
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - G. Kang
- Korea Institute of Science and Technology Information, Daejeon, 34141 Korea
| | - J. B. Kanner
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - S. Karki
- University of Oregon, Eugene, OR 97403 USA
| | - K. S. Karvinen
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - M. Kasprzack
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - Y. Kataoka
- Tokyo Institute of Technology, Graduate School of Science and Technology, 2-12-1, Ookayama, Meguro-ku, Tokyo 152-8551 Japan
| | - E. Katsavounidis
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - W. Katzman
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - S. Kaufer
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - T. Kaur
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - K. Kawabe
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - N. Kawai
- Tokyo Institute of Technology, Graduate School of Science and Technology, 2-12-1, Ookayama, Meguro-ku, Tokyo 152-8551 Japan
| | - S. Kawamura
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - F. Kéfélian
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - D. Keitel
- Universitat de les Illes Balears, IAC3—IEEC, E-07122 Palma de Mallorca, Spain
| | | | - R. Kennedy
- The University of Sheffield, Sheffield, S10 2TN United Kingdom
| | - J. S. Key
- University of Washington Bothell, 18115 Campus Way NE, Bothell, WA 98011 USA
| | - F. Y. Khalili
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | - I. Khan
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
| | - S. Khan
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - Z. Khan
- Institute for Plasma Research, Bhat, Gandhinagar 382428 India
| | - E. A. Khazanov
- Institute of Applied Physics, Nizhny Novgorod, 603950 Russia
| | | | - C. Kim
- Korea Astronomy and Space Science Institute (KASI), 776, Daedeokdae-ro, Yuseong-gu, Daejeon 34055 Republic of Korea
| | - H. Kim
- National Institute for Mathematical Sciences, Daejeon, 34047 Korea
| | - J. C. Kim
- Inje University, 197 Inje-ro, Gimhae-si, 50834 Korea
| | - J. Kim
- Myongji University, Yongin, 449-728 Korea
| | - W. Kim
- University of Adelaide, Adelaide, South Australia 5005 Australia
| | - Y.-M. Kim
- Pusan National University, Busan, 609-735 Korea
- Seoul National University, Seoul, 151-742 Korea
| | - S. J. Kimbrell
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - N. Kimura
- High Energy Accelerator Research Organization, 1-1, Oho, Tsukuba-shi, Ibaraki 305-0801 Japan
| | - E. J. King
- University of Adelaide, Adelaide, South Australia 5005 Australia
| | - P. J. King
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - R. Kirchhoff
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - J. S. Kissel
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - B. Klein
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | | | - S. Klimenko
- University of Florida, Gainesville, FL 32611 USA
| | - P. Koch
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - S. M. Koehlenbeck
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - Y. Kojima
- Hiroshima University, Department of Physical Science, 1-3-1, Kagamiyama, Higashihiroshima-shi, Hiroshima 739-8526 Japan
| | - K. Kokeyama
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - S. Koley
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | - K. Komori
- The University of Tokyo, Department of Physics, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - V. Kondrashov
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - A. Kontos
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - M. Korobko
- Universität Hamburg, D-22761 Hamburg, Germany
| | - W. Z. Korth
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - K. Kotake
- Department of Applied Physics, Fukuoka University, Fukuoka, Jonan, Nanakuma 814-0180 Japan
| | - I. Kowalska
- Astronomical Observatory Warsaw University, 00-478 Warsaw, Poland
| | - D. B. Kozak
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - C. Krämer
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - V. Kringel
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - B. Krishnan
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - A. Królak
- NCBJ, 05-400 Świerk-Otwock, Poland
- Institute of Mathematics, Polish Academy of Sciences, 00656 Warsaw, Poland
| | - G. Kuehn
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - P. Kumar
- Canadian Institute for Theoretical Astrophysics, University of Toronto, Toronto, Ontario M5S 3H8 Canada
| | - Rahul Kumar
- High Energy Accelerator Research Organization, 1-1, Oho, Tsukuba-shi, Ibaraki 305-0801 Japan
| | - Rakesh Kumar
- Institute for Plasma Research, Bhat, Gandhinagar 382428 India
| | - L. Kuo
- National Tsing Hua University, Hsinchu City, 30013 Taiwan Republic of China
| | - K. Kuroda
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | | | - Y. Kuwahara
- The University of Tokyo, Department of Physics, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - B. D. Lackey
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
- Syracuse University, Syracuse, NY 13244 USA
| | - M. Landry
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - R. N. Lang
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - J. Lange
- Rochester Institute of Technology, Rochester, NY 14623 USA
| | - B. Lantz
- Stanford University, Stanford, CA 94305 USA
| | - R. K. Lanza
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - A. Lartaux-Vollard
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - P. D. Lasky
- The School of Physics & Astronomy, Monash University, Clayton, 3800 Victoria Australia
| | - M. Laxen
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - A. Lazzarini
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - C. Lazzaro
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - P. Leaci
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - S. Leavey
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - E. O. Lebigot
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - C. H. Lee
- Pusan National University, Busan, 609-735 Korea
| | - H. K. Lee
- Hanyang University, Seoul, 133-791 Korea
| | - H. M. Lee
- Seoul National University, Seoul, 151-742 Korea
| | - H. W. Lee
- Inje University, 197 Inje-ro, Gimhae-si, 50834 Korea
| | - K. Lee
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - J. Lehmann
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - A. Lenon
- West Virginia University, Morgantown, WV 26506 USA
- Center for Gravitational Waves and Cosmology, West Virginia University, Morgantown, WV 26505 USA
| | - M. Leonardi
- Università di Trento, Dipartimento di Fisica, I-38123 Povo, Trento Italy
- INFN, Trento Institute for Fundamental Physics and Applications, I-38123 Povo, Trento Italy
| | - J. R. Leong
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - N. Leroy
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - N. Letendre
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - Y. Levin
- The School of Physics & Astronomy, Monash University, Clayton, 3800 Victoria Australia
| | - T. G. F. Li
- The Chinese University of Hong Kong, Shatin, NT Hong Kong
| | - A. Libson
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | | | - J. Liu
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - N. A. Lockerbie
- SUPA, University of Strathclyde, Glasgow, G1 1XQ United Kingdom
| | - A. L. Lombardi
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - L. T. London
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - J. E. Lord
- Syracuse University, Syracuse, NY 13244 USA
| | - M. Lorenzini
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | | | - M. Lormand
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - G. Losurdo
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - J. D. Lough
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - C. O. Lousto
- Rochester Institute of Technology, Rochester, NY 14623 USA
| | - G. Lovelace
- California State University Fullerton, Fullerton, CA 92831 USA
| | - H. Lück
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - A. P. Lundgren
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - R. Lynch
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - Y. Ma
- Caltech CaRT, Pasadena, CA 91125 USA
| | - S. Macfoy
- SUPA, University of the West of Scotland, Paisley, PA1 2BE United Kingdom
| | - B. Machenschalk
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - M. MacInnis
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - D. M. Macleod
- Louisiana State University, Baton Rouge, LA 70803 USA
| | | | | | | | - V. Malvezzi
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - N. Man
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - V. Mandic
- University of Minnesota, Minneapolis, MN 55455 USA
| | - V. Mangano
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - S. Mano
- The Institute of Statistical Mathematics, Department of Mathematical Analysis and Statistical Inference, 10-3 Midori-cho, Tachikawa, Tokyo 190-8562 Japan
| | - G. L. Mansell
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - M. Manske
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - M. Mantovani
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - F. Marchesoni
- INFN, Sezione di Perugia, I-06123 Perugia, Italy
- Università di Camerino, Dipartimento di Fisica, I-62032 Camerino, Italy
| | - M. Marchio
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - F. Marion
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - S. Márka
- Columbia University, New York, NY 10027 USA
| | - Z. Márka
- Columbia University, New York, NY 10027 USA
| | | | - E. Maros
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - F. Martelli
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - L. Martellini
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - I. W. Martin
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - D. V. Martynov
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - K. Mason
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - A. Masserot
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - T. J. Massinger
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - M. Masso-Reid
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - S. Mastrogiovanni
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - F. Matichard
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - L. Matone
- Columbia University, New York, NY 10027 USA
| | - N. Matsumoto
- Tohoku University, Sendai, Miyagi 982-0826 Japan
| | - F. Matsushima
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | - N. Mavalvala
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - N. Mazumder
- Washington State University, Pullman, WA 99164 USA
| | - R. McCarthy
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - D. E. McClelland
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - S. McCormick
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - C. McGrath
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - S. C. McGuire
- Southern University and A&M College, Baton Rouge, LA 70813 USA
| | - G. McIntyre
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - J. McIver
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - D. J. McManus
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - T. McRae
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - S. T. McWilliams
- West Virginia University, Morgantown, WV 26506 USA
- Center for Gravitational Waves and Cosmology, West Virginia University, Morgantown, WV 26505 USA
| | - D. Meacher
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
- The Pennsylvania State University, University Park, PA 16802 USA
| | - G. D. Meadors
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - J. Meidam
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | - A. Melatos
- The University of Melbourne, Parkville, Victoria 3010 Australia
| | - G. Mendell
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - D. Mendoza-Gandara
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - R. A. Mercer
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - E. L. Merilh
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - M. Merzougui
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - S. Meshkov
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - C. Messenger
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - C. Messick
- The Pennsylvania State University, University Park, PA 16802 USA
| | - R. Metzdorff
- Laboratoire Kastler Brossel, UPMC-Sorbonne Universités, CNRS, ENS-PSL Research University, Collège de France, F-75005 Paris, France
| | - P. M. Meyers
- University of Minnesota, Minneapolis, MN 55455 USA
| | - F. Mezzani
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - H. Miao
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - C. Michel
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - Y. Michimura
- The University of Tokyo, Department of Physics, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - H. Middleton
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | | | - L. Milano
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
- Università di Napoli ’Federico II’, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - A. L. Miller
- University of Florida, Gainesville, FL 32611 USA
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - A. Miller
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - B. B. Miller
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - J. Miller
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | | | - Y. Minenkov
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - J. Ming
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - S. Mirshekari
- Instituto de Física Teórica, University Estadual Paulista/ICTP South American Institute for Fundamental Research, São Paulo, SP 01140-070 Brazil
| | - C. Mishra
- International Centre for Theoretical Sciences, Tata Institute of Fundamental Research, Bengaluru, 560089 India
| | - V. P. Mitrofanov
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | | | - R. Mittleman
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - O. Miyakawa
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - A. Miyamoto
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - T. Miyamoto
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - S. Miyoki
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - A. Moggi
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - M. Mohan
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | | | - M. Montani
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - B. C. Moore
- Montclair State University, Montclair, NJ 07043 USA
| | - C. J. Moore
- University of Cambridge, Cambridge, CB2 1TN United Kingdom
| | - D. Moraru
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - G. Moreno
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - W. Morii
- The Kyoto University, Disaster Prevention Research Institute, Gokasho, Uji, Kyoto 611-0011 Japan
| | - S. Morisaki
- The University of Tokyo, Research Center for the Early Universe, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - Y. Moriwaki
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | - S. R. Morriss
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - B. Mours
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - C. M. Mow-Lowry
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - G. Mueller
- University of Florida, Gainesville, FL 32611 USA
| | - A. W. Muir
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - Arunava Mukherjee
- International Centre for Theoretical Sciences, Tata Institute of Fundamental Research, Bengaluru, 560089 India
| | - D. Mukherjee
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - S. Mukherjee
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - N. Mukund
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - A. Mullavey
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - J. Munch
- University of Adelaide, Adelaide, South Australia 5005 Australia
| | - E. A. M. Muniz
- California State University Fullerton, Fullerton, CA 92831 USA
| | - P. G. Murray
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - A. Mytidis
- University of Florida, Gainesville, FL 32611 USA
| | - S. Nagano
- National Institute of Information and Communications Technology, The Applied Electromagnetic Research Institute , 4-2-1, Nukuikita-machi, Koganei-shi, Tokyo 184-8795 Japan
| | - K. Nakamura
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - T. Nakamura
- Kyoto University, Department of Physics, Astronomy, Oiwake-cho, KitaShirakawa, Sakyou-ku, Kyoto-shi, Kyoto 606-8502 Japan
| | - H. Nakano
- Kyoto University, Department of Physics, Astronomy, Oiwake-cho, KitaShirakawa, Sakyou-ku, Kyoto-shi, Kyoto 606-8502 Japan
| | - Masaya Nakano
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | - Masayuki Nakano
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - K. Nakao
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - K. Napier
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - I. Nardecchia
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - T. Narikawa
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - L. Naticchioni
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - G. Nelemans
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | | | - M. Neri
- Università degli Studi di Genova, I-16146 Genova, Italy
- INFN, Sezione di Genova, I-16146 Genova, Italy
| | - M. Nery
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - A. Neunzert
- University of Michigan, Ann Arbor, MI 48109 USA
| | | | - G. Newton
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - T. T. Nguyen
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - W.-T. Ni
- National Tsing Hua University, Department of Physics, No. 101, Section 2, Kuang-Fu Road, Hsinchu, Taiwan 30013 ROC
- University of Shanghai for Science and Technology, School of Optical-Electrical and Computer Engineering, 516, Jun Gong Rd, Shanghai, 200093 P. R. China
| | - A. B. Nielsen
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - S. Nissanke
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - A. Nitz
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - A. Noack
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - F. Nocera
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - D. Nolting
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | | | | | - J. Oberling
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - E. Ochsner
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - E. Oelker
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - G. H. Ogin
- Whitman College, 345 Boyer Avenue, Walla Walla, WA 99362 USA
| | - J. J. Oh
- National Institute for Mathematical Sciences, Daejeon, 34047 Korea
| | - S. H. Oh
- National Institute for Mathematical Sciences, Daejeon, 34047 Korea
| | - M. Ohashi
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - N. Ohishi
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - M. Ohkawa
- Niigata University, Faculty of Engineering, 8050, Ikarashi-2-no-cho, Nishi-ku, Niigata-shi, Niigata 950-2181 Japan
| | - F. Ohme
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - K. Okutomi
- Sokendai (The Graduate University for Advanced Studies), 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - M. Oliver
- Universitat de les Illes Balears, IAC3—IEEC, E-07122 Palma de Mallorca, Spain
| | - K. Ono
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - Y. Ono
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | - K. Oohara
- Niigata University, Graduate School of Science and Technology, 8050, Ikarashi-2-no-cho, Nishi-ku, Niigata-shi, Niigata, 950-2181 Japan
| | - P. Oppermann
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | | | - B. O’Reilly
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | | | - D. J. Ottaway
- University of Adelaide, Adelaide, South Australia 5005 Australia
| | - H. Overmier
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - B. J. Owen
- Texas Tech University, Lubbock, TX 79409 USA
| | - A. E. Pace
- The Pennsylvania State University, University Park, PA 16802 USA
| | - J. Page
- University of Alabama in Huntsville, Huntsville, AL 35899 USA
| | - A. Pai
- IISER-TVM, CET Campus, Trivandrum Kerala, 695016 India
| | | | | | - O. Palashov
- Institute of Applied Physics, Nizhny Novgorod, 603950 Russia
| | - C. Palomba
- INFN, Sezione di Roma, I-00185 Roma, Italy
| | | | - H. Pan
- National Tsing Hua University, Hsinchu City, 30013 Taiwan Republic of China
| | - C. Pankow
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - F. Pannarale
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | | | - F. Paoletti
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - A. Paoli
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - M. A. Papa
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | | | - W. Parker
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - D. Pascucci
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - A. Pasqualetti
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - R. Passaquieti
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | | | - B. Patricelli
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | | | - M. Pedraza
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - R. Pedurand
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
- Université de Lyon, F-69361 Lyon, France
| | | | - A. Pele
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - F. E. Peña Arellano
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - S. Penn
- Hobart and William Smith Colleges, Geneva, NY 14456 USA
| | - C. J. Perez
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - A. Perreca
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - L. M. Perri
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - H. P. Pfeiffer
- Canadian Institute for Theoretical Astrophysics, University of Toronto, Toronto, Ontario M5S 3H8 Canada
| | - M. Phelps
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - O. J. Piccinni
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - M. Pichot
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - F. Piergiovanni
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - V. Pierro
- University of Sannio at Benevento, I-82100 Benevento, Italy
- INFN, Sezione di Napoli, I-80100 Napoli, Italy
| | - G. Pillant
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - L. Pinard
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - I. M. Pinto
- University of Sannio at Benevento, I-82100 Benevento, Italy
- INFN, Sezione di Napoli, I-80100 Napoli, Italy
| | - M. Pitkin
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - M. Poe
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - R. Poggiani
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - P. Popolizio
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - A. Post
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - J. Powell
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - J. Prasad
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - J. W. W. Pratt
- Embry-Riddle Aeronautical University, Prescott, AZ 86301 USA
| | - V. Predoi
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - T. Prestegard
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
- University of Minnesota, Minneapolis, MN 55455 USA
| | - M. Prijatelj
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - M. Principe
- University of Sannio at Benevento, I-82100 Benevento, Italy
- INFN, Sezione di Napoli, I-80100 Napoli, Italy
| | - S. Privitera
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - G. A. Prodi
- Università di Trento, Dipartimento di Fisica, I-38123 Povo, Trento Italy
- INFN, Trento Institute for Fundamental Physics and Applications, I-38123 Povo, Trento Italy
| | - L. G. Prokhorov
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | - O. Puncken
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - M. Punturo
- INFN, Sezione di Perugia, I-06123 Perugia, Italy
| | - P. Puppo
- INFN, Sezione di Roma, I-00185 Roma, Italy
| | - M. Pürrer
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - H. Qi
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - J. Qin
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - S. Qiu
- The School of Physics & Astronomy, Monash University, Clayton, 3800 Victoria Australia
| | - V. Quetschke
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - E. A. Quintero
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - F. J. Raab
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - D. S. Rabeling
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - H. Radkins
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - P. Raffai
- MTA Eötvös University, “Lendulet” Astrophysics Research Group, Budapest, 1117 Hungary
| | - S. Raja
- RRCAT, Indore, MP 452013 India
| | | | - M. Rakhmanov
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - P. Rapagnani
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - V. Raymond
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - M. Razzano
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - V. Re
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - J. Read
- California State University Fullerton, Fullerton, CA 92831 USA
| | - T. Regimbau
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - L. Rei
- INFN, Sezione di Genova, I-16146 Genova, Italy
| | - S. Reid
- SUPA, University of the West of Scotland, Paisley, PA1 2BE United Kingdom
| | - D. H. Reitze
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
- University of Florida, Gainesville, FL 32611 USA
| | - H. Rew
- College of William and Mary, Williamsburg, VA 23187 USA
| | | | - E. Rhoades
- Embry-Riddle Aeronautical University, Prescott, AZ 86301 USA
| | - F. Ricci
- INFN, Sezione di Roma, I-00185 Roma, Italy
- Università di Roma ’La Sapienza’, I-00185 Roma, Italy
| | - K. Riles
- University of Michigan, Ann Arbor, MI 48109 USA
| | - M. Rizzo
- Rochester Institute of Technology, Rochester, NY 14623 USA
| | - N. A. Robertson
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - R. Robie
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - F. Robinet
- LAL, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay, France
| | - A. Rocchi
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
| | - L. Rolland
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - J. G. Rollins
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - V. J. Roma
- University of Oregon, Eugene, OR 97403 USA
| | - R. Romano
- Università di Salerno, Fisciano, I-84084 Salerno Italy
- INFN, Sezione di Napoli, Complesso Universitario di Monte S.Angelo, I-80126 Napoli, Italy
| | - J. H. Romie
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - D. Rosińska
- Nicolaus Copernicus Astronomical Center, Polish Academy of Sciences, 00-716 Warsaw, Poland
- Janusz Gil Institute of Astronomy, University of Zielona Góra, 65-265 Zielona Góra, Poland
| | - S. Rowan
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - A. Rüdiger
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - P. Ruggi
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - K. Ryan
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - S. Sachdev
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - T. Sadecki
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - L. Sadeghian
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - N. Sago
- Kyushu University, Faculty of Arts and Science, 744, Motooka, Nishi-ku, Fukuoka 819-0395 Japan
| | - M. Saijo
- Waseda University, Department of Physics, 3-4-1, Okubo, Shinjuku, Tokyo 169-8555 Japan
| | - Y. Saito
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - K. Sakai
- Nagaoka University of Technology, Department of Information Science and Control Engineering, 1603-1 Kamitomioka, Nagaoka, Niigata 940-2188 Japan
| | - M. Sakellariadou
- King’s College London, University of London, London, WC2R 2LS United Kingdom
| | - L. Salconi
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - M. Saleem
- IISER-TVM, CET Campus, Trivandrum Kerala, 695016 India
| | - F. Salemi
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - A. Samajdar
- IISER-Kolkata, Mohanpur, West Bengal 741252 India
| | - L. Sammut
- The School of Physics & Astronomy, Monash University, Clayton, 3800 Victoria Australia
| | - L. M. Sampson
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - E. J. Sanchez
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - V. Sandberg
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | | | - Y. Sasaki
- Nagaoka University of Technology, Department of Information & Management Systems Engineering, 1603-1 Kamitomioka, Nagaoka, Niigata 940-2188 Japan
| | - B. Sassolas
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - B. S. Sathyaprakash
- The Pennsylvania State University, University Park, PA 16802 USA
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - S. Sato
- Hosei University, The Graduate School of Science and Engineering, Kajino-cho 3-7-2, Koganei-shi, Tokyo 184-8584 Japan
| | - T. Sato
- Niigata University, Faculty of Engineering, 8050, Ikarashi-2-no-cho, Nishi-ku, Niigata-shi, Niigata 950-2181 Japan
| | | | - O. Sauter
- University of Michigan, Ann Arbor, MI 48109 USA
| | - R. L. Savage
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - A. Sawadsky
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - P. Schale
- University of Oregon, Eugene, OR 97403 USA
| | - J. Scheuer
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - E. Schmidt
- Embry-Riddle Aeronautical University, Prescott, AZ 86301 USA
| | - J. Schmidt
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - P. Schmidt
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
- Caltech CaRT, Pasadena, CA 91125 USA
| | - R. Schnabel
- Universität Hamburg, D-22761 Hamburg, Germany
| | | | | | - E. Schreiber
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - D. Schuette
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - B. F. Schutz
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - S. G. Schwalbe
- Embry-Riddle Aeronautical University, Prescott, AZ 86301 USA
| | - J. Scott
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - S. M. Scott
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - T. Sekiguchi
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - Y. Sekiguchi
- Toho University, Faculty of Science, 2-2-1 Miyama, Funabashi-shi, Chiba Japan
| | - D. Sellers
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - A. S. Sengupta
- Indian Institute of Technology, Gandhinagar Ahmedabad, Gujarat 382424 India
| | - D. Sentenac
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | - V. Sequino
- INFN, Sezione di Roma Tor Vergata, I-00133 Roma, Italy
- Università di Roma Tor Vergata, I-00133 Roma, Italy
| | - A. Sergeev
- Institute of Applied Physics, Nizhny Novgorod, 603950 Russia
| | - Y. Setyawati
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - D. A. Shaddock
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | | | - M. S. Shahriar
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - B. Shapiro
- Stanford University, Stanford, CA 94305 USA
| | - P. Shawhan
- University of Maryland, College Park, MD 20742 USA
| | - A. Sheperd
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - M. Shibata
- Center for Gravitational Physics, Yukawa Institute for Theoretical Physics, Kyoto University, Kyoto, 606-8502 Japan
| | - Y. Shikano
- Institute for Molecular Science, National Institutes of Natural Sciences, 38 Nishigo-Naka, Myodaiji, Okazaki 444-8585 Japan
- Institute for Quantum Studies, Chapman University, 1 University Dr, Orange, CA 92866 USA
| | - T. Shimoda
- The University of Tokyo, Department of Physics, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - A. Shoda
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - D. H. Shoemaker
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - D. M. Shoemaker
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - K. Siellez
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - X. Siemens
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - M. Sieniawska
- Nicolaus Copernicus Astronomical Center, Polish Academy of Sciences, 00-716 Warsaw, Poland
| | - D. Sigg
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - A. D. Silva
- Instituto Nacional de Pesquisas Espaciais, 12227-010 São José dos Campos, São Paulo Brazil
| | - A. Singer
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - L. P. Singer
- NASA/Goddard Space Flight Center, Greenbelt, MD 20771 USA
| | - A. Singh
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - R. Singh
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - A. Singhal
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
| | - A. M. Sintes
- Universitat de les Illes Balears, IAC3—IEEC, E-07122 Palma de Mallorca, Spain
| | - B. J. J. Slagmolen
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - B. Smith
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - J. R. Smith
- California State University Fullerton, Fullerton, CA 92831 USA
| | - R. J. E. Smith
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - K. Somiya
- Tokyo Institute of Technology, Graduate School of Science and Technology, 2-12-1, Ookayama, Meguro-ku, Tokyo 152-8551 Japan
| | - E. J. Son
- National Institute for Mathematical Sciences, Daejeon, 34047 Korea
| | - B. Sorazu
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | | | - T. Souradeep
- Inter-University Centre for Astronomy and Astrophysics, Pune, 411007 India
| | - A. P. Spencer
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | | | - A. Staley
- Columbia University, New York, NY 10027 USA
| | - M. Steinke
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - J. Steinlechner
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - S. Steinlechner
- Universität Hamburg, D-22761 Hamburg, Germany
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - D. Steinmeyer
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - B. C. Stephens
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - S. P. Stevenson
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - R. Stone
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - K. A. Strain
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - N. Straniero
- Laboratoire des Matériaux Avancés (LMA), CNRS/IN2P3, F-69622 Villeurbanne, France
| | - G. Stratta
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - S. E. Strigin
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | - R. Sturani
- Instituto de Física Teórica, University Estadual Paulista/ICTP South American Institute for Fundamental Research, São Paulo, SP 01140-070 Brazil
| | - A. L. Stuver
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - Y. Sugimoto
- University of Toyama, 3190 Gofuku, Toyama-shi, Toyama 930-8555 Japan
| | | | - L. Sun
- The University of Melbourne, Parkville, Victoria 3010 Australia
| | - S. Sunil
- Institute for Plasma Research, Bhat, Gandhinagar 382428 India
| | - P. J. Sutton
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - T. Suzuki
- High Energy Accelerator Research Organization, 1-1, Oho, Tsukuba-shi, Ibaraki 305-0801 Japan
| | - B. L. Swinkels
- European Gravitational Observatory (EGO), I-56021 Cascina, Pisa Italy
| | | | - M. Tacca
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/Irfu, Observatoire de Paris, Sorbonne Paris Cité, F-75205 Paris Cedex 13 France
| | - H. Tagoshi
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - S. Takada
- National Institutes of Natural Sciences, The Device Engineering and Applied Physics Research Division, 322-6 Oroshi-cho, Toki city, GIFU Prefecture 509-5292 Japan
| | - H. Takahashi
- Nagaoka University of Technology, Department of Information & Management Systems Engineering, 1603-1 Kamitomioka, Nagaoka, Niigata 940-2188 Japan
| | - R. Takahashi
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - A. Takamori
- The University of Tokyo, Earthquake Research Institute, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-0032 Japan
| | | | - H. Tanaka
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - K. Tanaka
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - T. Tanaka
- Kyoto University, Department of Physics, Astronomy, Oiwake-cho, KitaShirakawa, Sakyou-ku, Kyoto-shi, Kyoto 606-8502 Japan
| | - D. B. Tanner
- University of Florida, Gainesville, FL 32611 USA
| | - M. Tápai
- University of Szeged, Dóm tér 9, Szeged, 6720 Hungary
| | - A. Taracchini
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - D. Tatsumi
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - R. Taylor
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - S. Telada
- National Institute of Advanced Industrial Science and Technology, Metrology Institute of Japan, 1-1-1, Umezono, Tsukuba-shi, Ibaraki 305-8568 Japan
| | - T. Theeg
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - E. G. Thomas
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - M. Thomas
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - P. Thomas
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - K. A. Thorne
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - E. Thrane
- The School of Physics & Astronomy, Monash University, Clayton, 3800 Victoria Australia
| | - T. Tippens
- Center for Relativistic Astrophysics and School of Physics, Georgia Institute of Technology, Atlanta, GA 30332 USA
| | - S. Tiwari
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
- INFN, Trento Institute for Fundamental Physics and Applications, I-38123 Povo, Trento Italy
| | - V. Tiwari
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - K. V. Tokmakov
- SUPA, University of Strathclyde, Glasgow, G1 1XQ United Kingdom
| | - K. Toland
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - T. Tomaru
- High Energy Accelerator Research Organization, 1-1, Oho, Tsukuba-shi, Ibaraki 305-0801 Japan
| | - C. Tomlinson
- The University of Sheffield, Sheffield, S10 2TN United Kingdom
| | - M. Tonelli
- Università di Pisa, I-56127 Pisa, Italy
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
| | - Z. Tornasi
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - C. I. Torrie
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - D. Töyrä
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - F. Travasso
- Università di Perugia, I-06123 Perugia, Italy
- INFN, Sezione di Perugia, I-06123 Perugia, Italy
| | - G. Traylor
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - D. Trifirò
- The University of Mississippi, University, MS 38677 USA
| | - J. Trinastic
- University of Florida, Gainesville, FL 32611 USA
| | - M. C. Tringali
- Università di Trento, Dipartimento di Fisica, I-38123 Povo, Trento Italy
- INFN, Trento Institute for Fundamental Physics and Applications, I-38123 Povo, Trento Italy
| | - L. Trozzo
- INFN, Sezione di Pisa, I-56127 Pisa, Italy
- Università di Siena, I-53100 Siena, Italy
| | - M. Tse
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - R. Tso
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - K. Tsubono
- The University of Tokyo, Department of Physics, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - T. Tsuzuki
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | - M. Turconi
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - D. Tuyenbayev
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - T. Uchiyama
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - T. Uehara
- University of Florida, Gainesville, FL 32611 USA
- National Defense Academy of Japan, Department of Communications Engineering, Hashirimizu 1-10-20, Yokosuka-shi, Kanagawa-Pref 239-8686 Japan
| | - S. Ueki
- Nagaoka University of Technology, Department of Information & Management Systems Engineering, 1603-1 Kamitomioka, Nagaoka, Niigata 940-2188 Japan
| | - K. Ueno
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - D. Ugolini
- Trinity University, San Antonio, TX 78212 USA
| | | | - A. L. Urban
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - T. Ushiba
- The University of Tokyo, Department of Physics, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - S. A. Usman
- Cardiff University, Cardiff, CF24 3AA United Kingdom
| | - H. Vahlbruch
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - G. Vajente
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - G. Valdes
- The University of Texas Rio Grande Valley, Brownsville, TX 78520 USA
| | - N. van Bakel
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
| | | | - J. F. J. van den Brand
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- VU University Amsterdam, 1081 HV Amsterdam, The Netherlands
| | | | | | | | | | - M. H. P. M. van Putten
- Physics and Astronomy, Sejong University, 209 Neungdong-ro, Gwangjin-gu, 143-747 Seoul South Korea
| | | | - M. Vardaro
- Università di Padova, Dipartimento di Fisica e Astronomia, I-35131 Padova, Italy
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - V. Varma
- Caltech CaRT, Pasadena, CA 91125 USA
| | - S. Vass
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - M. Vasúth
- Wigner RCP, RMKI, Konkoly Thege Miklós út 29-33, H-1121 Budapest, Hungary
| | - A. Vecchio
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - G. Vedovato
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - J. Veitch
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - P. J. Veitch
- University of Adelaide, Adelaide, South Australia 5005 Australia
| | | | - G. Venugopalan
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - D. Verkindt
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - F. Vetrano
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - A. Viceré
- Università degli Studi di Urbino ’Carlo Bo’, I-61029 Urbino, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - A. D. Viets
- University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201 USA
| | - S. Vinciguerra
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - D. J. Vine
- SUPA, University of the West of Scotland, Paisley, PA1 2BE United Kingdom
| | - J.-Y. Vinet
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - S. Vitale
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - T. Vo
- Syracuse University, Syracuse, NY 13244 USA
| | - H. Vocca
- Università di Perugia, I-06123 Perugia, Italy
- INFN, Sezione di Perugia, I-06123 Perugia, Italy
| | - C. Vorvick
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - D. V. Voss
- University of Florida, Gainesville, FL 32611 USA
| | - W. D. Vousden
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - S. P. Vyatchanin
- Faculty of Physics, Lomonosov Moscow State University, Moscow, 119991 Russia
| | - A. R. Wade
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - M. Wade
- Kenyon College, Gambier, OH 43022 USA
| | - T. Wakamatsu
- Niigata University, Graduate School of Science and Technology, 8050, Ikarashi-2-no-cho, Nishi-ku, Niigata-shi, Niigata, 950-2181 Japan
| | - M. Walker
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - L. Wallace
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - S. Walsh
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - G. Wang
- INFN, Gran Sasso Science Institute, I-67100 L’Aquila, Italy
- INFN, Sezione di Firenze, I-50019 Sesto Fiorentino, Firenze Italy
| | - H. Wang
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - M. Wang
- University of Birmingham, Birmingham, B15 2TT United Kingdom
| | - Y. Wang
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - R. L. Ward
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - J. Warner
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - M. Was
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | - J. Watchi
- Université Libre de Bruxelles, Brussels, 1050 Belgium
| | - B. Weaver
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - L.-W. Wei
- Artemis, Université Côte d’Azur, CNRS, Observatoire Côte d’Azur, CS 34229, F-06304 Nice Cedex 4, France
| | - M. Weinert
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - A. J. Weinstein
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - R. Weiss
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - L. Wen
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - P. Weßels
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - T. Westphal
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - K. Wette
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - J. T. Whelan
- Rochester Institute of Technology, Rochester, NY 14623 USA
| | | | - C. Whittle
- The School of Physics & Astronomy, Monash University, Clayton, 3800 Victoria Australia
| | - D. Williams
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - R. D. Williams
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | | - J. L. Willis
- Abilene Christian University, Abilene, TX 79699 USA
| | - B. Willke
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - M. H. Wimmer
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - W. Winkler
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - C. C. Wipf
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - H. Wittel
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Leibniz Universität Hannover, D-30167 Hannover, Germany
| | - G. Woan
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - J. Woehler
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - J. Worden
- LIGO Hanford Observatory, Richland, WA 99352 USA
| | - J. L. Wright
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - D. S. Wu
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
| | - G. Wu
- LIGO Livingston Observatory, Livingston, LA 70754 USA
| | - W. Yam
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - H. Yamamoto
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - K. Yamamoto
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - T. Yamamoto
- The University of Tokyo, Institute for Cosmic Ray Research, Higashi-Mozumi 238, Kamioka-cho, Hida-shi, Gifu 506-1205 Japan
| | - C. C. Yancey
- University of Maryland, College Park, MD 20742 USA
| | - K. Yano
- Tokyo Institute of Technology, Graduate School of Science and Technology, 2-12-1, Ookayama, Meguro-ku, Tokyo 152-8551 Japan
| | - M. J. Yap
- Australian National University, Canberra, Australian Capital Territory 0200 Australia
| | - J. Yokoyama
- The University of Tokyo, Research Center for the Early Universe, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
| | - T. Yokozawa
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - T. H. Yoon
- Department of Physics, Korea University, 145, Anam-ro, Seongbuk-gu, Seoul 02841 Korea
| | - Hang Yu
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - Haocun Yu
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - H. Yuzurihara
- Osaka City University, Department of Physics, 3-3-138, Sugimoto-cho, Sumiyosi-ku, Osaka-shi, Osaka 558-8585 Japan
| | - M. Yvert
- Laboratoire d’Annecy-le-Vieux de Physique des Particules (LAPP), Université Savoie Mont Blanc, CNRS/IN2P3, F-74941 Annecy-le-Vieux, France
| | | | | | - M. Zanolin
- Embry-Riddle Aeronautical University, Prescott, AZ 86301 USA
| | - S. Zeidler
- National Astronomical Observatory of Japan, 2-21-1, Ohsawa, Mitaka-shi, Tokyo 181-8588 Japan
| | | | - M. Zevin
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - L. Zhang
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | - M. Zhang
- College of William and Mary, Williamsburg, VA 23187 USA
| | - T. Zhang
- SUPA, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - Y. Zhang
- Rochester Institute of Technology, Rochester, NY 14623 USA
| | - C. Zhao
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - M. Zhou
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - Z. Zhou
- Center for Interdisciplinary Exploration & Research in Astrophysics (CIERA), Northwestern University, Evanston, IL 60208 USA
| | - S. J. Zhu
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-30167 Hannover, Germany
- Albert-Einstein-Institut, Max-Planck-Institut für Gravitationsphysik, D-14476 Potsdam-Golm, Germany
| | - X. J. Zhu
- University of Western Australia, Crawley, Western Australia 6009 Australia
| | - M. E. Zucker
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
- LIGO, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - J. Zweizig
- LIGO, California Institute of Technology, Pasadena, CA 91125 USA
| | | |
Collapse
|
38
|
Aikawa S, Kano K, Inoue A, Wang J, Saigusa D, Nagamatsu T, Hirota Y, Fujii T, Tsuchiya S, Taketomi Y, Sugimoto Y, Murakami M, Arita M, Kurano M, Ikeda H, Yatomi Y, Chun J, Aoki J. Autotaxin-lysophosphatidic acid-LPA 3 signaling at the embryo-epithelial boundary controls decidualization pathways. EMBO J 2017; 36:2146-2160. [PMID: 28588064 PMCID: PMC5509998 DOI: 10.15252/embj.201696290] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2016] [Revised: 04/12/2017] [Accepted: 05/02/2017] [Indexed: 12/21/2022] Open
Abstract
During pregnancy, up-regulation of heparin-binding (HB-) EGF and cyclooxygenase-2 (COX-2) in the uterine epithelium contributes to decidualization, a series of uterine morphological changes required for placental formation and fetal development. Here, we report a key role for the lipid mediator lysophosphatidic acid (LPA) in decidualization, acting through its G-protein-coupled receptor LPA3 in the uterine epithelium. Knockout of Lpar3 or inhibition of the LPA-producing enzyme autotaxin (ATX) in pregnant mice leads to HB-EGF and COX-2 down-regulation near embryos and attenuates decidual reactions. Conversely, selective pharmacological activation of LPA3 induces decidualization via up-regulation of HB-EGF and COX-2. ATX and its substrate lysophosphatidylcholine can be detected in the uterine epithelium and in pre-implantation-stage embryos, respectively. Our results indicate that ATX-LPA-LPA3 signaling at the embryo-epithelial boundary induces decidualization via the canonical HB-EGF and COX-2 pathways.
Collapse
Affiliation(s)
- Shizu Aikawa
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan
| | - Kuniyuki Kano
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.,Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan
| | - Asuka Inoue
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.,Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO), Kawaguchi, Saitama, Japan
| | - Jiao Wang
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan
| | - Daisuke Saigusa
- Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.,Department of Integrative Genomics, Tohoku Medical Megabank, Tohoku University, Sendai, Miyagi, Japan
| | - Takeshi Nagamatsu
- Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - Yasushi Hirota
- Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - Tomoyuki Fujii
- Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - Soken Tsuchiya
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Yoshitaka Taketomi
- Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.,Center for Disease Biology and Integrative Medicine Graduate School of Medicine The University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - Yukihiko Sugimoto
- Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.,Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Makoto Murakami
- Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.,Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.,Center for Disease Biology and Integrative Medicine Graduate School of Medicine The University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - Makoto Arita
- RIKEN, Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.,Graduate School of Pharmaceutical Sciences, Keio University, Minato-ku, Tokyo, Japan
| | - Makoto Kurano
- Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.,Department of Clinical Laboratory, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan
| | - Hitoshi Ikeda
- Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.,Department of Clinical Laboratory, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan
| | - Yutaka Yatomi
- Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan.,Department of Clinical Laboratory, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan
| | - Jerold Chun
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
| | - Junken Aoki
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan .,Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology (AMED-CREST), Chiyoda-ku, Tokyo, Japan
| |
Collapse
|
39
|
Yano A, Takahashi Y, Moriguchi H, Inazumi T, Koga T, Otaka A, Sugimoto Y. An aromatic amino acid within intracellular loop 2 of the prostaglandin EP2 receptor is a prerequisite for selective association and activation of Gαs. Biochim Biophys Acta Mol Cell Biol Lipids 2017; 1862:615-622. [PMID: 28336329 DOI: 10.1016/j.bbalip.2017.03.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Revised: 03/17/2017] [Accepted: 03/18/2017] [Indexed: 10/19/2022]
Abstract
We previously demonstrated that the aromatic moiety of Tyr143 within the intracellular loop 2 (ICL2) region of the prostaglandin EP2 receptor plays a crucial role in Gs coupling. Here we investigated whether the ICL2 of the EP2 receptor directly binds to Gαs and whether an aromatic moiety affects this interaction. In Chinese hamster ovary cells, mutations of Tyr143 reduced the ability of the EP2 receptor to interact with G proteins as demonstrated by GTPγS sensitivity, as well as the ability of agonist-induced cAMP formation, with the rank order of Phe>Tyr (wild-type)=Trp>Leu>Ala (=0). We found that the wild-type ICL2 peptide (i2Y) and its mutant with Phe at Tyr143 (i2F) inhibited receptor-G protein complex formation of wild-type EP2 in membranes, whereas the Ala-substituted mutant (i2A) did not. Specific interactions between these peptides and the Gαs protein were detected by surface plasmon resonance, but Gαs showed different association rates, with a rank order of i2F>i2Y≫i2A, with similar dissociation rates. Moreover, i2F and i2Y, but not i2A activated membrane adenylyl cyclase. These results indicate that the ICL2 region of the EP2 receptor is its potential interaction site with Gαs, and that the aromatic side chain moiety at position 143 is a determinant for the accessibility of the ICL2 to the Gαs protein.
Collapse
Affiliation(s)
- Akiko Yano
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Yuko Takahashi
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Hiromi Moriguchi
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Tomoaki Inazumi
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; AMED-CREST, Tokyo 100-0004, Japan
| | - Tomoaki Koga
- Priority Organization for Innovation and Excellence, Kumamoto University, Kumamoto, Japan
| | - Akira Otaka
- Department of Bioorganic Synthetic Chemistry, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan
| | - Yukihiko Sugimoto
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; AMED-CREST, Tokyo 100-0004, Japan.
| |
Collapse
|
40
|
Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, Sugimoto Y, Ozawa T, Nakamura M, Kumagai M, Watashi K, Taketo MM, Aoki T, Narumiya S, Oshima M, Arita M, Hara E, Ohtani N. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE 2-Mediated Suppression of Antitumor Immunity. Cancer Discov 2017; 7:522-538. [PMID: 28202625 DOI: 10.1158/2159-8290.cd-16-0932] [Citation(s) in RCA: 279] [Impact Index Per Article: 39.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2016] [Revised: 02/13/2017] [Accepted: 02/13/2017] [Indexed: 12/21/2022]
Abstract
Obesity increases the risk of cancers, including hepatocellular carcinomas (HCC). However, the precise molecular mechanisms through which obesity promotes HCC development are still unclear. Recent studies have shown that gut microbiota may influence liver diseases by transferring its metabolites and components. Here, we show that the hepatic translocation of obesity-induced lipoteichoic acid (LTA), a Gram-positive gut microbial component, promotes HCC development by creating a tumor-promoting microenvironment. LTA enhances the senescence-associated secretory phenotype (SASP) of hepatic stellate cells (HSC) collaboratively with an obesity-induced gut microbial metabolite, deoxycholic acid, to upregulate the expression of SASP factors and COX2 through Toll-like receptor 2. Interestingly, COX2-mediated prostaglandin E2 (PGE2) production suppresses the antitumor immunity through a PTGER4 receptor, thereby contributing to HCC progression. Moreover, COX2 overexpression and excess PGE2 production were detected in HSCs in human HCCs with noncirrhotic, nonalcoholic steatohepatitis (NASH), indicating that a similar mechanism could function in humans.Significance: We showed the importance of the gut-liver axis in obesity-associated HCC. The gut microbiota-driven COX2 pathway produced the lipid mediator PGE2 in senescent HSCs in the tumor microenvironment, which plays a pivotal role in suppressing antitumor immunity, suggesting that PGE2 and its receptor may be novel therapeutic targets for noncirrhotic NASH-associated HCC. Cancer Discov; 7(5); 522-38. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 443.
Collapse
Affiliation(s)
- Tze Mun Loo
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan
| | - Fumitaka Kamachi
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan
| | - Yoshihiro Watanabe
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan
| | - Shin Yoshimoto
- Division of Cancer Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
- LSI Medience Corporation, Tokyo, Japan
| | - Hiroaki Kanda
- Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Yuriko Arai
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan
- Division of Cancer Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Yaeko Nakajima-Takagi
- Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
| | - Atsushi Iwama
- Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
| | - Tomoaki Koga
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| | - Takayuki Ozawa
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan
| | - Masaru Nakamura
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan
| | - Miho Kumagai
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan
| | - Koichi Watashi
- Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
- CREST, Japan Science and Technology Agency (JST), Saitama, Japan
| | - Makoto M Taketo
- Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-Konoé-cho, Kyoto, Japan
| | - Tomohiro Aoki
- Center for Innovation in Immunoregulation Technology and Therapeutics, Kyoto University Graduate School of Medicine, Konoe-cho Yoshida, Kyoto, Japan
| | - Shuh Narumiya
- Center for Innovation in Immunoregulation Technology and Therapeutics, Kyoto University Graduate School of Medicine, Konoe-cho Yoshida, Kyoto, Japan
- Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
- AMED-CREST, AMED, Japan Agency for Medical Research and Development, Tokyo, Japan
| | - Masanobu Oshima
- AMED-CREST, AMED, Japan Agency for Medical Research and Development, Tokyo, Japan
- Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
| | - Makoto Arita
- Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan
- Graduate School of Medical Life Science, Yokohama City University, Kanagawa, Japan
- PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan
- Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan
| | - Eiji Hara
- Division of Cancer Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
- AMED-CREST, AMED, Japan Agency for Medical Research and Development, Tokyo, Japan
- Department of Molecular Microbiology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
| | - Naoko Ohtani
- Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
- PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan
| |
Collapse
|
41
|
Babiker HAE, Saito T, Nakatsu Y, Takasuga S, Morita M, Sugimoto Y, Ueda J, Watanabe T. Molecular cloning, polymorphism, and functional activity of the bovine and water buffalo Mx2 gene promoter region. Springerplus 2016; 5:2109. [PMID: 28066698 PMCID: PMC5179478 DOI: 10.1186/s40064-016-3729-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/27/2016] [Accepted: 11/23/2016] [Indexed: 12/27/2022]
Abstract
Background Bovine Mx2 gene sequences were already reported, but further information about the gene properties is not yet available. The objective of the current study was to elucidate the structural properties of the bovine Mx2 gene mainly the promoter region and its possible functional role. If available, such information would help in assessing the functional properties of the gene, which was reported to confer antiviral action against recombinant VSV. Results Examinations on the bovine genomic BAC clone—confirmed to contain the Mx2 gene—revealed 883-bp sequences. A computer scan unequivocally identified a 788-bp promoter region containing a typical TATA box, three ISREs and other promoter-specific motifs. Comparative analysis of nine bovine genomic DNA samples showed 19 nucleotide substitutions suggesting the existence of five different genotypes in the promoter region. The water buffalo Mx2 promoter region was determined by using primers based on the bovine Mx2 promoter region disclosing 893-bp, with 56 substitutions, two insertions, 9 and 1 nt at two different sites. A functional analysis of the putative ISRE indicated that ISRE played a synergetic role in the activation of bovine Mx2 gene transcription. Conclusion Bovine and water buffalo Mx2 promoter region was identified disclosing, the conserved ISRE, located in the proximal end of the promoter region like other members of the antiviral family, suggesting functional activity under interferon stimulation.
Collapse
Affiliation(s)
- H A E Babiker
- Graduate School of Agriculture, Hokkaido University, Sapporo, 060-8589 Japan ; Faculty of Veterinary Medicine, Khartoum University, P.O. Box 32, Shambat, Khartoum Sudan
| | - T Saito
- Graduate School of Agriculture, Hokkaido University, Sapporo, 060-8589 Japan
| | - Y Nakatsu
- Graduate School of Agriculture, Hokkaido University, Sapporo, 060-8589 Japan
| | - S Takasuga
- Shirakawa Institute of Animal Genetics, Livestock Technology Association, Shirakawa, Fukushima 961-8061 Japan
| | - M Morita
- Shirakawa Institute of Animal Genetics, Livestock Technology Association, Shirakawa, Fukushima 961-8061 Japan
| | - Y Sugimoto
- Shirakawa Institute of Animal Genetics, Livestock Technology Association, Shirakawa, Fukushima 961-8061 Japan
| | - J Ueda
- Institute of Dairy Science, Rakuno Gakuen University, Ebetsu, Hokkaido 069-8501 Japan
| | - T Watanabe
- Graduate School of Agriculture, Hokkaido University, Sapporo, 060-8589 Japan
| |
Collapse
|
42
|
Hirano T, Okazaki A, Sasaki S, Suzuki Y, Hara H, Sugimoto Y, Hanzawa K. P6014 Mapping and exome sequencing of a weak calf syndrome with premature birth. J Anim Sci 2016. [DOI: 10.2527/jas2016.94supplement4155x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
43
|
Sasaki S, Uemoto Y, Sasago N, Abe T, Nishimura S, Sugimoto Y. Polymorphisms associated with four reproductive traits have no adverse effects on meat traits in Japanese Black cattle. Anim Genet 2016; 47:386-7. [PMID: 26857291 DOI: 10.1111/age.12414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/11/2015] [Indexed: 12/01/2022]
Affiliation(s)
- S Sasaki
- National Livestock Breeding Center, Odakura, Nishigo, Fukushima, 961-8511, Japan
| | - Y Uemoto
- National Livestock Breeding Center, Odakura, Nishigo, Fukushima, 961-8511, Japan
| | - N Sasago
- National Livestock Breeding Center, Odakura, Nishigo, Fukushima, 961-8511, Japan
| | - T Abe
- National Livestock Breeding Center, Odakura, Nishigo, Fukushima, 961-8511, Japan
| | - S Nishimura
- Shirakawa Institute of Animal Genetics, Japan Livestock Technology Association, Odakura, Nishigo, Fukushima, 961-8061, Japan
| | - Y Sugimoto
- Shirakawa Institute of Animal Genetics, Japan Livestock Technology Association, Odakura, Nishigo, Fukushima, 961-8061, Japan
| |
Collapse
|
44
|
Tsuchiya H, Hohjoh H, Fujiwara Y, Sugimoto Y, Koshimizu TA. Prostaglandin D2 elicits the reversible neurite retraction in hypothalamic cell line. Biochem Biophys Res Commun 2016; 470:804-10. [PMID: 26820529 DOI: 10.1016/j.bbrc.2016.01.091] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2015] [Accepted: 01/15/2016] [Indexed: 12/19/2022]
Abstract
Prostaglandins (PGs) play important roles in diverse physiological processes in the central nervous system. PGD2 is the most abundant PG in the brain and acts through specific receptors, DP1 and CRTH2. We investigated the effects of PGD2 on the morphology of the hypothalamic cell line mHypoE-N37 (N37). In N37 cells, serum starvation induced neurite outgrowth and PGD2 elicited neurite retraction, although we failed to detect transcripts for DP1 and CRTH2. Such an effect of PGD2 was efficiently mimicked by its metabolite, 15-deoxy-Δ(12,14)-prostaglandin J2. N-acetyl cysteine completely abolished the effect of PGD2, and reactive oxygen species (ROS) were considered to be important. Notably, neurite outgrowth was restored by PGD2 removal. These results suggest that PGD2 induces reversible neurite retraction in a ROS-mediated mechanism that does not involve any known receptor.
Collapse
Affiliation(s)
- Hiroyoshi Tsuchiya
- Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi 329-0498, Japan.
| | - Hirofumi Hohjoh
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Yoko Fujiwara
- Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi 329-0498, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Taka-Aki Koshimizu
- Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi 329-0498, Japan
| |
Collapse
|
45
|
Inada M, Takita M, Yokoyama S, Watanabe K, Tominari T, Matsumoto C, Hirata M, Maru Y, Maruyama T, Sugimoto Y, Narumiya S, Uematsu S, Akira S, Murphy G, Nagase H, Miyaura C. Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis. J Biol Chem 2015; 290:29781-93. [PMID: 26475855 DOI: 10.1074/jbc.m115.669481] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2015] [Indexed: 01/11/2023] Open
Abstract
The stromal cells associated with tumors such as melanoma are significant determinants of tumor growth and metastasis. Using membrane-bound prostaglandin E synthase 1 (mPges1(-/-)) mice, we show that prostaglandin E2 (PGE2) production by host tissues is critical for B16 melanoma growth, angiogenesis, and metastasis to both bone and soft tissues. Concomitant studies in vitro showed that PGE2 production by fibroblasts is regulated by direct interaction with B16 cells. Autocrine activity of PGE2 further regulates the production of angiogenic factors by fibroblasts, which are key to the vascularization of both primary and metastatic tumor growth. Similarly, cell-cell interactions between B16 cells and host osteoblasts modulate mPGES-1 activity and PGE2 production by the osteoblasts. PGE2, in turn, acts to stimulate receptor activator of NF-κB ligand expression, leading to osteoclast differentiation and bone erosion. Using eicosanoid receptor antagonists, we show that PGE2 acts on osteoblasts and fibroblasts in the tumor microenvironment through the EP4 receptor. Metastatic tumor growth and vascularization in soft tissues was abrogated by an EP4 receptor antagonist. EP4-null Ptger4(-/-) mice do not support B16 melanoma growth. In vitro, an EP4 receptor antagonist modulated PGE2 effects on fibroblast production of angiogenic factors. Our data show that B16 melanoma cells directly influence host stromal cells to generate PGE2 signals governing neoangiogenesis and metastatic growth in bone via osteoclast erosive activity as well as angiogenesis in soft tissue tumors.
Collapse
Affiliation(s)
- Masaki Inada
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan, the Global Innovation Research Organization, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan
| | - Morichika Takita
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan, the Department of Pharmacology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
| | - Satoshi Yokoyama
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan
| | - Kenta Watanabe
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan
| | - Tsukasa Tominari
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan, the Global Innovation Research Organization, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan
| | - Chiho Matsumoto
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan
| | - Michiko Hirata
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan
| | - Yoshiro Maru
- the Department of Pharmacology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
| | - Takayuki Maruyama
- the Minase Research Institutes, Ono Pharmaceutical Co. Ltd, Osaka 618-8585, Japan
| | - Yukihiko Sugimoto
- the Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Science, Kumamoto University, Kumamoto 862-0973, Japan
| | - Shuh Narumiya
- the Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
| | - Satoshi Uematsu
- the Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan, the Department of Mucosal Immunology, School of Medicine, Chiba University, Chiba 260-8670, Japan, the Division of Innate Immune, Regulation, International Research, and Development, Center for Mucosal Vaccines, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
| | - Shizuo Akira
- the Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
| | - Gillian Murphy
- the Global Innovation Research Organization, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan, the Department of Oncology, University of Cambridge, Cancer Research UK, Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom, and
| | - Hideaki Nagase
- the Global Innovation Research Organization, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan, the Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7FY, United Kingdom
| | - Chisato Miyaura
- From the Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan, the Global Innovation Research Organization, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan,
| |
Collapse
|
46
|
Tamura T, Morita E, Kawai S, Sasakabe T, Fukuda N, Sugimoto Y, Suma S, Mokuno J, Nakagawa H, Hishida A, Okada R, Naito M, Hamajima N, Wakai K. Significant Associations of Abdominal Obesity with LYPLAL1 Polymorphism (rs4846567) among a General Japanese Population: A Cross-Sectional Study. Int J Epidemiol 2015. [DOI: 10.1093/ije/dyv096.441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
47
|
Sasakabe T, Yin G, Naito M, Morita E, Kawai S, Okada R, Tamura T, Nakagawa H, Suma S, Fukuda N, Sugimoto Y, Wakai K, Hamajima N, Study Group JM. The Association of Alcohol Intake with Serum Lipid Profile and its Modification by ADH1B and ALDH2 Polymorphisms: J-MICC Study. Int J Epidemiol 2015. [DOI: 10.1093/ije/dyv096.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Kawahara K, Suenobu M, Ohtsuka H, Kuniyasu A, Sugimoto Y, Nakagomi M, Fukasawa H, Shudo K, Nakayama H. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease. J Alzheimers Dis 2015; 42:587-605. [PMID: 24916544 DOI: 10.3233/jad-132720] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Alzheimer's disease (AD) is a neurodegenerative process involving amyloid-β (Aβ) peptide deposition, neuroinflammation, and progressive memory loss. Here, we evaluated whether oral administration of retinoic acid receptor (RAR)α,β agonist Am80 (tamibarotene) or specific retinoid X receptor (RXR) pan agonist HX630 or their combination could improve deficits in an AD model, 8.5-month-old amyloid-β protein precursor 23 (AβPP23) mice. Co-administration of Am80 (0.5 mg/kg) and HX630 (5 mg/kg) for 17 days significantly improved memory deficits (Morris water maze) in AβPP23 mice, whereas administration of either agent alone produced no effect. Only co-administration significantly reduced the level of insoluble Aβ peptide in the brain. These results thus indicate that effective memory improvement via reduction of insoluble Aβ peptide in 8.5-month-old AβPP23 mice requires co-activation of RARα,β and RXRs. RARα-positive microglia accumulated Aβ plaques in the AβPP23 mice. Rat primary microglia co-treated with Am80/HX630 showed increased degradation activity towards 125I-labeled oligomeric Aβ1-42 peptide in an insulin-degrading enzyme (IDE)-dependent manner. The co-administration increased mRNA for IDE and membrane-associated IDE protein in vivo, suggesting that IDE contributes to Aβ clearance in Am80/HX630-treated AβPP23 mice. Am80/HX630 also increased IL-4Rα expression in microglial MG5 cells. The improvement in memory of Am80/HX630-treated AβPP23 mice was correlated with the levels and signaling of hippocampal interleukin-4 (IL-4). Therefore, Am80/HX630 may promote differentiation of IL-4-responsive M2-like microglia and increase their activity for clearance of oligomeric Aβ peptides by restoring impaired IL-4 signaling in AβPP23 mice. Combination treatment with RAR and RXR agonists may be an effective approach for AD therapy.
Collapse
Affiliation(s)
- Kohichi Kawahara
- Department of Molecular Cell Function, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
| | - Michita Suenobu
- Department of Molecular Cell Function, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
| | - Hideyuki Ohtsuka
- Department of Molecular Cell Function, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
| | - Akihiko Kuniyasu
- Department of Molecular Cell Function, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
| | - Yukihiko Sugimoto
- Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
| | - Madoka Nakagomi
- Research Foundation ITSUU Laboratory, Setagaya-ku, Tokyo, Japan
| | | | - Koichi Shudo
- Research Foundation ITSUU Laboratory, Setagaya-ku, Tokyo, Japan
| | - Hitoshi Nakayama
- Department of Molecular Cell Function, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
| |
Collapse
|
49
|
Abstract
Genotype imputation facilitates the identification of missing genotypes on a high-density array using low-density arrays and has great potential for reducing genotyping costs for cattle populations. However, the imputation quality varies across breeds, which have different effective population sizes. Therefore, the accuracy of genotype imputation must be evaluated in each breed. The Japanese Black cattle population has a unique genetic background, and this study aimed to investigate different factors affecting imputation quality in this population. A total of 1368 animals were genotyped using the Illumina BovineHD BeadChip, and the accuracy of imputation was evaluated using information from four lower density arrays. The extent of linkage disequilibrium for this population was relatively higher than that in other beef breeds but lower than that in dairy breeds. The accuracy of arrays with more than 20 000 single nucleotide polymorphisms (SNPs) was similar to or higher than that of lower density arrays. In addition, the minor allele frequency of SNPs in the reference population affected the accuracy. The accuracy increased as the size of the reference population increased, up to 400 animals, beyond which there was little increase. A higher genetic relationship between the reference and test populations increased imputation accuracy. These results indicate that high imputation accuracy can be achieved using high-density arrays, having enough reference animals and including relatives in the reference population.
Collapse
Affiliation(s)
- Y Uemoto
- National Livestock Breeding Center, Nishigo, Fukushima, 961-8511, Japan
| | - S Sasaki
- National Livestock Breeding Center, Nishigo, Fukushima, 961-8511, Japan
| | - Y Sugimoto
- Shirakawa Institute of Animal Genetics, Japan Livestock Technology Association, Nishigo, Fukushima, 961-8511, Japan
| | - T Watanabe
- National Livestock Breeding Center, Nishigo, Fukushima, 961-8511, Japan
| |
Collapse
|
50
|
Ikeda K, Tomimoto S, Tsuchiya S, Hamagami KI, Shintani N, Sugimoto Y, Ichikawa A, Kasai A, Nakazawa T, Nagayasu K, Hayata-Takano A, Baba A, Hashimoto H. Comparative gene expression profiles in pancreatic islets associated with agouti yellow mutation and PACAP overexpression in mice. Biochem Biophys Rep 2015; 2:179-183. [PMID: 29124161 PMCID: PMC5668656 DOI: 10.1016/j.bbrep.2015.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2015] [Revised: 06/19/2015] [Accepted: 06/22/2015] [Indexed: 11/19/2022] Open
Abstract
In diabetes mellitus, pituitary adenylate cyclase-activating polypeptide (PACAP) has insulinotropic and glucose-lowering properties. We previously demonstrated that transgenic mice overexpressing PACAP in pancreatic β-cells (PACAP-Tg) show attenuated pancreatic islet hyperplasia and hyperinsulinemia in type 2 diabetic models. To explore the underlying mechanisms, here we crossed PACAP-Tg mice with lethal yellow agouti (KKAy) diabetic mice, and performed gene chip analysis of laser capture microdissected pancreatic islets from four F1 offspring genotypes (wild-type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy). We identified 1371 probes with >16-fold differences between at least one pair of genotypes, and classified the probes into five clusters with characteristic expression patterns. Gene ontology enrichment analysis showed that genes involved in the terms ribosome and intracellular organelles such as ribonucleoprotein complex, mitochondrion, and chromosome organization were significantly enriched in clusters characterized by up-regulated genes in PACAP-Tg:KKAy mice compared with KKAy mice. These results may provide insight into the mechanisms of diabetes that accompany islet hyperplasia and amelioration by PACAP. PACAP overexpressed in KKAy diabetic mice is known to exert antidiabetic effects. We performed gene chip analysis of pancreatic islets in these mice. Gene ontology analysis was performed for genes classified into five clusters. Genes involved in the terms ribosome, mitochondrion, and chromosome were enriched. These pathways may be involved in the mechanism by which PACAP ameliorates diabetes.
Collapse
Affiliation(s)
- Kazuya Ikeda
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.,Research Fellow of the Japan Society for the Promotion of Science, Japan
| | - Shuhei Tomimoto
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Soken Tsuchiya
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.,Department of Pharmaceutical Biochemistry, Kumamoto University Graduate School of Pharmaceutical Sciences, Oe-Honmachi, Kumamoto 862-0973, Japan
| | - Ken-Ichi Hamagami
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Norihito Shintani
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Yukihiko Sugimoto
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.,Department of Pharmaceutical Biochemistry, Kumamoto University Graduate School of Pharmaceutical Sciences, Oe-Honmachi, Kumamoto 862-0973, Japan
| | - Atsushi Ichikawa
- Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.,Institute for Biosciences, Mukogawa Women's University, 11-68 Koshien-Kyubancho, Nishinomiya-shi, Hyogo 663-8179, Japan
| | - Atsushi Kasai
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Takanobu Nakazawa
- iPS Cell-based Research Project on Brain Neuropharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Kazuki Nagayasu
- iPS Cell-based Research Project on Brain Neuropharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Atsuko Hayata-Takano
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Akemichi Baba
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.,Faculty of Pharmaceutical Sciences, Hyogo University of Health Science, 1-3-6 Minatojima, Chuo-ku, Kobe, Hyogo 650-8530, Japan
| | - Hitoshi Hashimoto
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.,iPS Cell-based Research Project on Brain Neuropharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.,Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| |
Collapse
|